Clive G. Ballard, MB ChB, MRCPsych, MD - Publications

Affiliations: 
Age-Related Diseases King's College London, London, UK 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=109

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ismail Z, Leon R, Creese B, Ballard C, Robert P, Smith EE. Optimizing detection of Alzheimer's disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO. Molecular Neurodegeneration. 18: 50. PMID 37516848 DOI: 10.1186/s13024-023-00631-6  0.327
2023 Chai YL, Lee JH, Chong JR, Ballard C, Francis PT, Kennedy BK, Arumugam TV, Chen CP, Aarsland D, Lai MKP. Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias. Journal of Neuroinflammation. 20: 111. PMID 37158957 DOI: 10.1186/s12974-023-02789-8  0.348
2023 Creese B, Arathimos R, Aarsland D, Ballard C, Brooker H, Hampshire A, Corbett A, Ismail Z. Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 9: e12386. PMID 37139261 DOI: 10.1002/trc2.12386  0.338
2022 Garcia MJ, Leadley R, Lang S, Ross J, Vinand E, Ballard C, Gsteiger S. Real-World Use of Symptomatic Treatments in Early Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36404542 DOI: 10.3233/JAD-220471  0.338
2022 Sabatini S, Martyr A, Ukoumunne OC, Ballard C, Collins R, Pentecost C, Rusted JM, Quinn C, Anstey KJ, Kim S, Corbett A, Brooker H, Clare L. Attitudes toward own aging and cognition among individuals living with and without dementia: findings from the IDEAL programme and the PROTECT study. Bmc Geriatrics. 22: 641. PMID 35927646 DOI: 10.1186/s12877-022-03336-5  0.322
2022 Tariot PN, Ballard C, Devanand DP, Cummings JL, Sultzer DL. Pimavanserin and dementia-related psychosis. The Lancet. Neurology. 21: 114-115. PMID 35065031 DOI: 10.1016/S1474-4422(21)00466-X  0.312
2022 Ismail Z, Creese B, Aarsland D, Kales HC, Lyketsos CG, Sweet RA, Ballard C. Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities. Nature Reviews. Neurology. PMID 34983978 DOI: 10.1038/s41582-021-00597-3  0.316
2021 Banerjee S, High J, Stirling S, Shepstone L, Swart AM, Telling T, Henderson C, Ballard C, Bentham P, Burns A, Farina N, Fox C, Francis P, Howard R, Knapp M, et al. Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 398: 1487-1497. PMID 34688369 DOI: 10.1016/S0140-6736(21)01210-1  0.304
2021 Tariot PN, Cummings JL, Soto-Martin ME, Ballard C, Erten-Lyons D, Sultzer DL, Devanand DP, Weintraub D, McEvoy B, Youakim JM, Stankovic S, Foff EP. Trial of Pimavanserin in Dementia-Related Psychosis. The New England Journal of Medicine. 385: 309-319. PMID 34289275 DOI: 10.1056/NEJMoa2034634  0.324
2021 Ballard C, Aarsland D. Relieving Caregiver Burden Through Evidence-Based Treatment for Dementia-Related Psychosis. The Journal of Clinical Psychiatry. 82. PMID 34232580 DOI: 10.4088/JCP.AD19038AH5C  0.305
2021 Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D. Parkinson disease-associated cognitive impairment. Nature Reviews. Disease Primers. 7: 47. PMID 34210995 DOI: 10.1038/s41572-021-00280-3  0.301
2020 Low CYB, Lee JH, Lim FTW, Lee C, Ballard C, Francis PT, Lai MKP, Tan MGK. Isoform-specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias. Brain Pathology (Zurich, Switzerland). e12917. PMID 33128789 DOI: 10.1111/bpa.12917  0.328
2020 Owens AP, Ballard C, Beigi M, Kalafatis C, Brooker H, Lavelle G, Brønnick KK, Sauer J, Boddington S, Velayudhan L, Aarsland D. Implementing Remote Memory Clinics to Enhance Clinical Care During and After COVID-19. Frontiers in Psychiatry. 11: 579934. PMID 33061927 DOI: 10.3389/Fpsyt.2020.579934  0.309
2020 Ballard C, Kales HC, Lyketsos C, Aarsland D, Creese B, Mills R, Williams H, Sweet RA. Psychosis in Alzheimer's Disease. Current Neurology and Neuroscience Reports. 20: 57. PMID 33048274 DOI: 10.1007/s11910-020-01074-y  0.329
2020 Bateman DR, Gill S, Hu S, Foster ED, Ruthirakuhan MT, Sellek AF, Mortby ME, Matušková V, Ng KP, Tarawneh RM, Freund-Levi Y, Kumar S, Gauthier S, Rosenberg PB, Ferreira de Oliveira F, ... ... Ballard C, et al. Agitation and impulsivity in mid and late life as possible risk markers for incident dementia. Alzheimer's & Dementia (New York, N. Y.). 6: e12016. PMID 32995467 DOI: 10.1002/Trc2.12016  0.445
2020 Khalifa K, Bergland AK, Soennesyn H, Oppedal K, Oesterhus R, Dalen I, Larsen AI, Fladby T, Brooker H, Wesnes KA, Ballard C, Aarsland D. Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial. Frontiers in Neurology. 11: 916. PMID 32982933 DOI: 10.3389/Fneur.2020.00916  0.438
2020 Delgado J, Jones L, Bradley MC, Allan LM, Ballard C, Clare L, Fortinsky RH, Hughes CM, Melzer D. Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes. Age and Ageing. PMID 32946561 DOI: 10.1093/Ageing/Afaa147  0.355
2020 Ballard C, Aarsland D, Cummings J, O'Brien J, Mills R, Molinuevo JL, Fladby T, Williams G, Doherty P, Corbett A, Sultana J. Drug repositioning and repurposing for Alzheimer disease. Nature Reviews. Neurology. PMID 32939050 DOI: 10.1038/S41582-020-0397-4  0.382
2020 Ball HA, McWhirter L, Ballard C, Bhome R, Blackburn DJ, Edwards MJ, Fleming SM, Fox NC, Howard R, Huntley J, Isaacs JD, Larner AJ, Nicholson TR, Pennington CM, Poole N, et al. Functional cognitive disorder: dementia's blind spot. Brain : a Journal of Neurology. PMID 32791521 DOI: 10.1093/Brain/Awaa224  0.409
2020 Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet (London, England). PMID 32738937 DOI: 10.1016/S0140-6736(20)30367-6  0.339
2020 Borda MG, Aarsland D, Tovar‐Rios DA, Giil LM, Ballard C, Gonzalez MC, Brønnick K, Alves G, Oppedal K, Soennesyn H, Vik‐Mo AO. Neuropsychiatric Symptoms and Functional Decline in Alzheimerʼs Disease and Lewy Body Dementia Journal of the American Geriatrics Society. PMID 32738062 DOI: 10.1111/Jgs.16709  0.447
2020 Ballard CG, Coate B, Abler V, Stankovic S, Foff E. Evaluation of the efficacy of pimavanserin in the treatment of agitation and aggression in patients with Alzheimer's disease psychosis: A post hoc analysis. International Journal of Geriatric Psychiatry. PMID 32729631 DOI: 10.1002/Gps.5381  0.331
2020 Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, ... ... Ballard C, et al. Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials. 21: 660. PMID 32684162 DOI: 10.1186/S13063-020-04608-4  0.329
2020 Husebo BS, Allore H, Achterberg W, Angeles RC, Ballard C, Bruvik FK, Fæø SE, Gedde MH, Hillestad E, Jacobsen FF, Kirkevold Ø, Kjerstad E, Kjome RLS, Mannseth J, Naik M, et al. LIVE@Home.Path-innovating the clinical pathway for home-dwelling people with dementia and their caregivers: study protocol for a mixed-method, stepped-wedge, randomized controlled trial. Trials. 21: 510. PMID 32517727 DOI: 10.1186/S13063-020-04414-Y  0.4
2020 Velayudhan L, Aarsland D, Ballard C. Mental health of people living with dementia in care homes during COVID-19 pandemic. International Psychogeriatrics. 1-2. PMID 32487278 DOI: 10.1017/S1041610220001088  0.331
2020 Mueller C, John C, Perera G, Aarsland D, Ballard C, Stewart R. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes. European Journal of Epidemiology. PMID 32415541 DOI: 10.1007/S10654-020-00643-2  0.379
2020 Ashton NJ, Hye A, Rajkumar AP, Leuzy A, Snowden S, Suárez-Calvet M, Karikari TK, Schöll M, La Joie R, Rabinovici GD, Höglund K, Ballard C, Hortobágyi T, Svenningsson P, Blennow K, et al. An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders. Nature Reviews. Neurology. 16: 265-284. PMID 32322100 DOI: 10.1038/S41582-020-0348-0  0.354
2020 Surr CA, Holloway I, Walwyn REA, Griffiths AW, Meads D, Martin A, Kelley R, Ballard C, Fossey J, Burnley N, Chenoweth L, Creese B, Downs M, Garrod L, Graham EH, et al. Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trial. Aging & Mental Health. 1-14. PMID 32279541 DOI: 10.1080/13607863.2020.1745144  0.327
2020 McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. PMID 32241955 DOI: 10.1212/Wnl.0000000000009323  0.433
2020 Surr CA, Holloway I, Walwyn RE, Griffiths AW, Meads D, Kelley R, Martin A, McLellan V, Ballard C, Fossey J, Burnley N, Chenoweth L, Creese B, Downs M, Garrod L, et al. Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT. Health Technology Assessment (Winchester, England). 24: 1-172. PMID 32216870 DOI: 10.3310/Hta24160  0.331
2020 O'Brien J, Taylor JP, Ballard C, Barker RA, Bradley C, Burns A, Collerton D, Dave S, Dudley R, Francis P, Gibbons A, Harris K, Lawrence V, Leroi I, McKeith I, et al. Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32213570 DOI: 10.1136/Jnnp-2019-322702  0.358
2020 Ballard C, Corbett A. Reducing psychotropic drug use in people with dementia living in nursing homes. International Psychogeriatrics. 32: 291-294. PMID 32192559 DOI: 10.1017/S1041610219001455  0.303
2020 Desai R, Charlesworth GM, Brooker HJ, Potts HWW, Corbett A, Aarsland D, Ballard CG. Temporal Relationship Between Depressive Symptoms and Cognition in Mid and Late Life: A Longitudinal Cohort Study. Journal of the American Medical Directors Association. PMID 32151550 DOI: 10.1016/J.Jamda.2020.01.106  0.322
2020 Pishva E, Creese B, Smith AR, Viechtbauer W, Proitsi P, van den Hove DLA, Ballard C, Mill J, Lunnon K. Psychosis-associated DNA methylomic variation in Alzheimer's disease cortex. Neurobiology of Aging. PMID 32007278 DOI: 10.1016/J.Neurobiolaging.2020.01.001  0.341
2019 Fischer CE, Ismail Z, Youakim JM, Creese B, Kumar S, Nuñez N, Darby RR, Di Vita A, D'Antonio F, de Lena C, McGeown WJ, Ramit R, Rasmussen J, Bell J, Wang H, ... ... Ballard C, et al. Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research. Journal of Alzheimer's Disease : Jad. PMID 31884469 DOI: 10.3233/Jad-190828  0.426
2019 Howard R, Zubko O, Bradley R, Harper E, Pank L, O'Brien J, Fox C, Tabet N, Livingston G, Bentham P, McShane R, Burns A, Ritchie C, Reeves S, Lovestone S, ... Ballard C, et al. Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial. Jama Neurology. PMID 31738372 DOI: 10.1001/Jamaneurol.2019.3762  0.419
2019 Meads DM, Martin A, Griffiths A, Kelley R, Creese B, Robinson L, McDermid J, Walwyn R, Ballard C, Surr CA. Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial. Applied Health Economics and Health Policy. PMID 31701483 DOI: 10.1007/S40258-019-00531-1  0.333
2019 Gatt A, Whitfield DR, Ballard C, Doherty P, Williams G. Alzheimer's Disease Progression in the 5×FAD Mouse Captured with a Multiplex Gene Expression Array. Journal of Alzheimer's Disease : Jad. PMID 31683485 DOI: 10.3233/Jad-190805  0.346
2019 Creese B, Vassos E, Bergh S, Athanasiu L, Johar I, Rongve A, Medbøen IT, Vasconcelos Da Silva M, Aakhus E, Andersen F, Bettella F, Braekhus A, Djurovic S, Paroni G, Proitsi P, ... ... Ballard C, et al. Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease. Translational Psychiatry. 9: 273. PMID 31641104 DOI: 10.1038/S41398-019-0592-5  0.323
2019 Vik-Mo AO, Giil LM, Borda MG, Ballard C, Aarsland D. The individual course of neuropsychiatric symptoms in people with Alzheimer's and Lewy body dementia: 12-year longitudinal cohort study. The British Journal of Psychiatry : the Journal of Mental Science. 1-6. PMID 31506117 DOI: 10.1192/Bjp.2019.195  0.392
2019 Williams G, Gatt A, Clarke E, Corcoran J, Doherty P, Chambers D, Ballard C. Drug repurposing for Alzheimer's disease based on transcriptional profiling of human iPSC-derived cortical neurons. Translational Psychiatry. 9: 220. PMID 31492831 DOI: 10.1038/S41398-019-0555-X  0.365
2019 Hase Y, Polvikoski TM, Firbank MJ, Craggs LJ, Hawthorne E, Platten C, Stevenson W, Deramecourt V, Ballard C, Kenny RA, Perry RH, Ince P, Carare RO, Allan LM, Horsburgh K, et al. Small Vessel Disease Pathological Changes in Neurodegenerative and Vascular Dementias concomitant with Autonomic Dysfunction. Brain Pathology (Zurich, Switzerland). PMID 31357238 DOI: 10.1111/Bpa.12769  0.458
2019 Rajkumar AP, Bidkhori G, Shoaie S, Clarke E, Morrin H, Hye A, Williams G, Ballard C, Francis P, Aarsland D. Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of Neuroinflammation. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 31327631 DOI: 10.1016/J.Jagp.2019.06.007  0.435
2019 Clarke E, Jantrachotechatchawan C, Buhidma Y, Broadstock M, Yu L, Howlett D, Aarsland D, Ballard C, Francis PT. Age-related neurochemical and behavioural changes in D409V/WT GBA1 mouse: Relevance to lewy body dementia. Neurochemistry International. 104502. PMID 31299418 DOI: 10.1016/J.Neuint.2019.104502  0.368
2019 El-Hayek YH, Wiley RE, Khoury CP, Daya RP, Ballard C, Evans AR, Karran M, Molinuevo JL, Norton M, Atri A. Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders. Journal of Alzheimer's Disease : Jad. PMID 31256142 DOI: 10.3233/Jad-190426  0.355
2019 Ballard C, Atri A, Boneva N, Cummings JL, Frölich L, Molinuevo JL, Tariot PN, Raket LL. Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 164-174. PMID 31193334 DOI: 10.1016/J.Trci.2019.04.001  0.419
2019 Erdal A, Ballard C, Vahia IV, Husebo BS. Analgesic treatments in people with dementia - how safe are they? A systematic review. Expert Opinion On Drug Safety. 18: 511-522. PMID 31038371 DOI: 10.1080/14740338.2019.1614166  0.355
2019 Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, ... ... Ballard C, et al. Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials. 20: 191. PMID 30944040 DOI: 10.1186/S13063-019-3259-X  0.341
2019 Koychev I, Lawson J, Chessell T, Mackay C, Gunn R, Sahakian B, Rowe JB, Thomas AJ, Rochester L, Chan D, Tom B, Malhotra P, Ballard C, Chessell I, Ritchie CW, et al. Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease. Bmj Open. 9: e024498. PMID 30904851 DOI: 10.1136/Bmjopen-2018-024498  0.408
2019 Creese B, Brooker H, Ismail Z, Wesnes KA, Hampshire A, Khan Z, Megalogeni M, Corbett A, Aarsland D, Ballard C. Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 30902566 DOI: 10.1016/J.Jagp.2019.01.215  0.37
2019 Brooker H, Wesnes KA, Ballard C, Hampshire A, Aarsland D, Khan Z, Stenton R, Megalogeni M, Corbett A. The relationship between the frequency of number puzzle use and baseline cognitive function in a large online sample of adults aged 50 and over. International Journal of Geriatric Psychiatry. PMID 30746778 DOI: 10.1002/Gps.5085  0.314
2019 Gatt A, Lee H, Williams G, Thuret S, Ballard C. Expression of neurogenic markers in Alzheimer's disease: a systematic review and metatranscriptional analysis. Neurobiology of Aging. 76: 166-180. PMID 30716542 DOI: 10.1016/J.Neurobiolaging.2018.12.016  0.352
2019 Cummings JL, Tong G, Ballard C. Treatment Combinations for Alzheimer's Disease: Current And Future Pharmacotherapy Options. Journal of Alzheimer's Disease : Jad. PMID 30689575 DOI: 10.3233/Jad-180766  0.375
2019 Frölich L, Atri A, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Geist MA, Raket LL, Cummings JL. Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 67: 303-313. PMID 30636738 DOI: 10.3233/Jad-180595  0.336
2019 Husebø BS, Ballard C, Aarsland D, Selbaek G, Slettebo DD, Gulla C, Aasmul I, Habiger T, Elvegaard T, Testad I, Flo E. The Effect of a Multicomponent Intervention on Quality of Life in Residents of Nursing Homes: A Randomized Controlled Trial (COSMOS). Journal of the American Medical Directors Association. 20: 330-339. PMID 30630722 DOI: 10.1016/J.Jamda.2018.11.006  0.316
2019 Mueller C, Soysal P, Rongve A, Isik AT, Thompson T, Maggi S, Smith L, Basso C, Stewart R, Ballard C, O'Brien JT, Aarsland D, Stubbs B, Veronese N. Survival time and differences between dementia with Lewy bodies and Alzheimer's disease following diagnosis: A meta-analysis of longitudinal studies. Ageing Research Reviews. PMID 30625375 DOI: 10.1016/J.Arr.2019.01.005  0.442
2019 Romeo R, Zala D, Knapp M, Orrell M, Fossey J, Ballard C. Improving the quality of life of care home residents with dementia: Cost-effectiveness of an optimized intervention for residents with clinically significant agitation in dementia Alzheimers & Dementia. 15: 282-291. PMID 30470592 DOI: 10.1016/J.Jalz.2018.08.010  0.326
2019 Vik-Mo AO, Bencze J, Ballard C, Hortobágyi T, Aarsland D. Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 90: 728-730. PMID 30054314 DOI: 10.1136/Jnnp-2018-318445  0.479
2019 Corbett A, Brooker H, Hampshire A, Williams G, Wesnes K, Aarsland D, Ballard C. P4-658: INTENSIVE SHORT-TERM ONLINE COGNITIVE TRAINING IN GRAMMATICAL REASONING CONFERS BENEFITS TO COGNITION AND FUNCTION IN OLDER ADULTS: OUTCOMES FROM THE START RANDOMISED CONTROLLED TRIAL Alzheimer's & Dementia. 15: P1583-P1583. DOI: 10.1016/J.Jalz.2019.09.024  0.305
2019 McDermid J, Ballard C. P4-627: No Improvement In Nursing Home Care For People With Dementia Since The Millennium Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.08.176  0.32
2019 Fox C, Hammond SP, Shepstone L, Poland F, Maclullich A, Cross J, Knapp MRJ, Henderson C, Sahota O, Penhale B, Backhouse T, Boustani MA, Howard RJ, Ballard C, Teale E. Dementia hospital care research programme: Peri-operative enhanced recovery hip fracture care of patients with dementia (perfected) - cluster randomised control trial results Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.08.171  0.331
2019 Silva MVD, Creese B, Johar I, Aarsland D, Bergh S, Athanasiu L, Rongve A, Medboen IT, Aakhus E, Andersen F, Braekhus A, Djurovic S, Saltvedt I, Seripa D, Stordal E, ... ... Ballard C, et al. P1-131: Genome Wide Association Study: Identifying Genetic Markers In Apathy In People With Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.686  0.324
2019 Silva MVD, Creese B, Johar I, Bergh S, Aarsland D, Rongve A, Medboen IT, Aakhus E, Andersen F, Braekhus A, Paroni G, Saltvedt I, Seripa D, Stordal E, Selbaek G, ... Ballard C, et al. O2-11-06: The Course Of Apathy In People With Dementia Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4516  0.332
2019 Velayudhan L, Ugochukwu A, Wesnes K, Brooker H, Corbett A, Aarsland D, Ballard C, Proitsi P. P3-555: An Online Assessment Of The Influence Of Vascular Risk Factors On Cognitive Function In Healthy Adults Aged 50 And Above Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3592  0.304
2019 Creese B, Brooker H, Corbett A, Aarsland D, Ballard C. P3-319: Family History Of Dementia With Psychotic Symptoms In The Cognitively Normal Population: Feasibility Of Measurement And Initial Clinical And Genetic Associations Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3351  0.364
2019 Femminella GD, Doef Tvd, Wang Y, Frangou E, Love S, Calsolaro V, Carver S, Holmes C, Ritchie CW, Lawrence RM, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, ... ... Ballard C, et al. P2-358: Insulin Resistance Influences Hippocampal Glucose Metabolism Rather Than Hippocampal Volume In Non-Diabetic Alzheimer'S Disease Patients Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2765  0.308
2019 Johar I, Creese B, Bergh S, Athanasiu L, Medboen IT, Silva MVD, Rongve A, Aakhus E, Anderson F, Bettella F, Braekhus A, Djurovic S, Paroni G, Proitsi P, Saltvedt I, ... ... Ballard C, et al. P2-129: Genome-Wide Association Of Alzheimer'S Disease With Dysphoria And Evaluation Of Genetic Overlap With Major Depressive Disorder Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2536  0.306
2019 Creese B, Brooker H, Wesnes K, Corbett A, Aarsland D, Ismail Z, Ballard C. P1-468: Characterising The Cognitive Profile Associated With Individual Domains Of Mid Behavioural Impairment In The Cognitively Normal Population Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1073  0.313
2019 Brooker H, Ballard C, Aarsland D, Khan Z, Wesnes K, Corbett A. P1-459: Informant- And Participant-Reported Cognitive Function Using The Iqcode Measure Is A Robust Indicator Of Cognitive Health Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1064  0.306
2019 Guskey M, Norton J, Coate B, Owen R, Stankovic S, Ballard C. A Post Hoc Analysis Of Study Acp-103-019 Evaluating The Impact Of A Reduction In Psychosis On The Severity Of Agitation And Aggression In Patients With Alzheimer'S Disease American Journal of Geriatric Psychiatry. 27. DOI: 10.1016/J.Jagp.2019.01.086  0.344
2018 Cummings JL, Atri A, Ballard C, Boneva N, Frölich L, Molinuevo JL, Raket LL, Tariot PN. Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program. Alzheimer's Research & Therapy. 10: 116. PMID 30474567 DOI: 10.1186/S13195-018-0443-2  0.313
2018 FitzGerald JM, Perera G, Chang-Tave A, Price A, Rajkumar AP, Bhattarai M, O'Brien JT, Ballard C, Aarsland D, Stewart R, Mueller C. The Incidence of Recorded Delirium Episodes Before and After Dementia Diagnosis: Differences Between Dementia With Lewy Bodies and Alzheimer's Disease. Journal of the American Medical Directors Association. PMID 30448339 DOI: 10.1016/J.Jamda.2018.09.021  0.473
2018 Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D. Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30387904 DOI: 10.1002/Mds.27488  0.376
2018 Silarova B, Nelis SM, Ashworth RM, Ballard C, Bieńkiewicz M, Henderson C, Hillman A, Hindle JV, Hughes JC, Lamont RA, Litherland R, Jones IR, Jones RW, Knapp M, Kotting P, et al. Protocol for the IDEAL-2 longitudinal study: following the experiences of people with dementia and their primary carers to understand what contributes to living well with dementia and enhances active life. Bmc Public Health. 18: 1214. PMID 30376832 DOI: 10.1186/S12889-018-6129-7  0.411
2018 Hayward JK, Nunez KM, Ballard C, Spector A. Healthy adjustment for new residents with dementia using SettleIN: A feasibility study in UK care homes. Dementia (London, England). 1471301218806082. PMID 30354443 DOI: 10.1177/1471301218806082  0.36
2018 Eraydin IE, Mueller C, Corbett A, Ballard C, Brooker H, Wesnes K, Aarsland D, Huntley J. Investigating the relationship between age of onset of depressive disorder and cognitive function. International Journal of Geriatric Psychiatry. PMID 30259558 DOI: 10.1002/Gps.4979  0.303
2018 Kales HC, Lyketsos CG, Miller EM, Ballard C. Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus. International Psychogeriatrics. 1-8. PMID 30068400 DOI: 10.1017/S1041610218000534  0.439
2018 Creese B, Albertyn CP, Dworkin S, Thomas RS, Wan YM, Ballard C. Executive function but not episodic memory decline associated with visual hallucinations in Parkinson's disease. Journal of Neuropsychology. PMID 30035858 DOI: 10.1111/Jnp.12169  0.348
2018 Aman Y, Pitcher T, Ballard C, Malcangio M. Impaired chronic pain-like behaviour and altered opioidergic system in the TASTPM mouse model of Alzheimer's disease. European Journal of Pain (London, England). PMID 29987897 DOI: 10.1002/Ejp.1288  0.304
2018 Vik-Mo AO, Giil LM, Ballard C, Aarsland D. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study. International Journal of Geriatric Psychiatry. 33: 1361-1369. PMID 29979473 DOI: 10.1002/Gps.4933  0.408
2018 Whitfield DR, Francis PT, Ballard C, Williams G. Associations between ZnT3, tau pathology, agitation, and delusions in dementia. International Journal of Geriatric Psychiatry. PMID 29856089 DOI: 10.1002/Gps.4908  0.475
2018 Erdal A, Flo E, Aarsland D, Selbæk G, Ballard C, Slettebø DD, Husebø B. Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM). Clinical Interventions in Aging. 13: 935-946. PMID 29805252 DOI: 10.2147/Cia.S161052  0.363
2018 Mueller C, Perera G, Rajkumar AP, Bhattarai M, Price A, O'Brien JT, Ballard C, Stewart R, Aarsland D. Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 143-152. PMID 29780862 DOI: 10.1016/J.Dadm.2017.12.001  0.399
2018 Creese B, Da Silva MV, Johar I, Ballard C. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease. Expert Review of Neurotherapeutics. PMID 29764230 DOI: 10.1080/14737175.2018.1476140  0.381
2018 Erdal A, Flo E, Aarsland D, Ballard C, Slettebø DD, Husebø B. Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM). Drugs & Aging. 35: 545-558. PMID 29725986 DOI: 10.1007/S40266-018-0546-2  0.303
2018 Ballard C, Lang I. Alcohol and dementia: a complex relationship with potential for dementia prevention. The Lancet. Public Health. PMID 29475811 DOI: 10.1016/S2468-2667(18)30031-8  0.357
2018 Pickett J, Bird C, Ballard C, Banerjee S, Brayne C, Cowan K, Clare L, Comas-Herrera A, Corner L, Daley S, Knapp M, Lafortune L, Livingston G, Manthorpe J, Marchant N, et al. A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025. International Journal of Geriatric Psychiatry. PMID 29468724 DOI: 10.1002/Gps.4868  0.342
2018 Ballard C, Banister C, Khan Z, Cummings J, Demos G, Coate B, Youakim JM, Owen R, Stankovic S. Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study. The Lancet. Neurology. 17: 213-222. PMID 29452684 DOI: 10.1016/S1474-4422(18)30039-5  0.373
2018 Ballard C, Corbett A, Orrell M, Williams G, Moniz-Cook E, Romeo R, Woods B, Garrod L, Testad I, Woodward-Carlton B, Wenborn J, Knapp M, Fossey J. Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial. Plos Medicine. 15: e1002500. PMID 29408901 DOI: 10.1371/Journal.Pmed.1002500  0.353
2018 Gatt A, Ekonomou A, Somani A, Thuret S, Howlett D, Corbett A, Johnson M, Perry E, Attems J, Francis P, Aarsland D, Ballard C. Importance of Proactive Treatment of Depression in Lewy Body Dementias: The Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study. Dementia and Geriatric Cognitive Disorders. 44: 283-293. PMID 29393203 DOI: 10.1159/000484437  0.432
2018 Bereczki E, Branca RM, Francis PT, Pereira JB, Baek JH, Hortobágyi T, Winblad B, Ballard C, Lehtiö J, Aarsland D. Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach. Brain : a Journal of Neurology. PMID 29324989 DOI: 10.1093/Brain/Awx352  0.431
2018 Becker RE, Greig NH, Lahiri DK, Bledsoe J, Majercik S, Ballard C, Aarsland D, Schneiderh LS, Flanagan D, Govindarajani R, Sano M, Ferrucci L, Kapogiannisk D. (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease. Current Alzheimer Research. PMID 29318971 DOI: 10.2174/1567205015666180110120026  0.394
2018 Atri A, Frölich L, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Windfeld K, Raket LL, Cummings JL. Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials. Jama. 319: 130-142. PMID 29318278 DOI: 10.1001/Jama.2017.20373  0.427
2018 Velayudhan L, Ffytche D, Ballard C, Aarsland D. New Therapeutic Strategies for Lewy Body Dementias. Current Neurology and Neuroscience Reports. 17: 68. PMID 28741230 DOI: 10.1007/S11910-017-0778-2  0.425
2018 Skogseth R, Hortobágyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D. Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology. Journal of Alzheimer's Disease : Jad. 59: 1139-1152. PMID 28731443 DOI: 10.3233/Jad-170274  0.397
2018 Weintraub D, Norton J, Coate B, Andersson C, Fredericks D, Ballard C. 122 Use of Pimavanserin in Patients With Parkinson’s Disease Psychosis: Subgroup Analysis of Efficacy and Safety in Patients With and Without Cognitive Impairment Cns Spectrums. 23: 77-77. DOI: 10.1017/S1092852918000202  0.347
2018 Richardson K, Loke Y, Savva GM, Howard RJ, Boyd P, Aldus C, Maidment ID, Steel N, Arthur A, Ballard C, Fox C. P4-387: Unintended Effects Of Z-Drugs (Zolpidem, Zopiclone And Zaleplon) In People Living With Dementia Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.07.211  0.347
2018 Creese B, Pishva E, Proitsi P, Smith RG, Ballard C, Hove DLAvd, Mill J, Lunnon K. P2-143: Psychosis-Associated Epigenetic Variation In Patients With Alzheimer'S Disease Across Cortical Brain Regions Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.829  0.336
2018 Brooker H, Creese B, Ismail Z, Khan Z, Megalogeni M, Corbett A, Hampshire A, Aarsland D, Ballard C, Wesnes K. P1-523: The Relationship Between The Mild Behavioural Impairment Checklist (Mbi-C) Total Score And Core Aspects Of Cognitive Function In Older Adults Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.534  0.301
2018 Ballard C, Romeo R, Knapp MRJ, Testad I, Fossey J. O5-07-05: Health Economic Analysis Of The Improving Well-Being And Health For People With Dementia (Wheld) Person-Centred Care Training For The Treatment Of Agitation In People With Dementia: A Cluster Randomized Controlled Trial Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.3035  0.338
2018 McDermid J, Fossey J, Silva MVD, Ballard C. O4-03-06: A Randomized Controlled Trial Evaluating The Impact Of An E-Learning Intervention Based On The Improving Well-Being And Health For People With Dementia (Wheld) Person-Centred Care Training Programme Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2926  0.301
2018 Ballard C, Murphy C. P4-017: Clinical Trial Pipelines For Alzheimer'S Disease Pose Challenges For Future Effective Treatment And Therapies Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2419  0.353
2018 Creese B, Bergh S, Aarsland D, Andersen F, Brooker H, Corbett A, Khan Z, Megalogeni M, Rongve A, Stordal E, Wesnes K, Ballard C, Selbaek G. Genetic Overlap Between Psychotic Symptoms Across The Lifespan: Findings From Schizophrenia, Cognitively Normal Older Adults And Alzheimer’S Disease Alzheimers & Dementia. 14: 335. DOI: 10.1016/J.Jalz.2018.06.155  0.301
2018 Ballard C, Youakim J, Coate B, Stankovic S. P3-002: Pimavanserin In Alzheimer'S Disease Psychosis: Subgroup Analysis Of The More Severe Population Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1357  0.355
2018 Erdal A, Flo E, Aarsland D, Ballard C, Husebø BS. P3-001: A Randomized, Placebo-Controlled Trial To Investigate Safety Of Buprenorphine Transdermal System For Pain Management In People With Dementia Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1356  0.315
2018 Wesnes K, Brooker H, Creese B, Khan Z, Megalogeni M, Corbett A, Davis K, Hotopf M, Aarsland D, Ballard C. P2-483: Depression Is Associated With Impairment In Cognitive Function In Adults Aged 50 And Over Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1176  0.314
2017 Hammond SP, Cross JL, Shepstone L, Backhouse T, Henderson C, Poland F, Sims E, MacLullich A, Penhale B, Howard R, Lambert N, Varley A, Smith TO, Sahota O, Donell S, ... ... Ballard C, et al. PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trial. Trials. 18: 583. PMID 29202786 DOI: 10.1186/S13063-017-2303-Y  0.333
2017 Lanctôt KL, Amatniek J, Ancoli-Israel S, Arnold SE, Ballard C, Cohen-Mansfield J, Ismail Z, Lyketsos C, Miller DS, Musiek E, Osorio RS, Rosenberg PB, Satlin A, Steffens D, Tariot P, et al. Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms. Alzheimer's & Dementia (New York, N. Y.). 3: 440-449. PMID 29067350 DOI: 10.1016/J.Trci.2017.07.001  0.439
2017 Huntley J, Corbett A, Wesnes K, Brooker H, Stenton R, Hampshire A, Ballard C. Online assessment of risk factors for dementia and cognitive function in healthy adults. International Journal of Geriatric Psychiatry. 33: e286-e293. PMID 28960500 DOI: 10.1002/Gps.4790  0.374
2017 Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC, et al. Dementia prevention, intervention, and care. Lancet (London, England). PMID 28735855 DOI: 10.1016/S0140-6736(17)31363-6  0.387
2017 Webster L, Groskreutz D, Grinbergs-Saull A, Howard R, O'Brien JT, Mountain G, Banerjee S, Woods B, Perneczky R, Lafortune L, Roberts C, McCleery J, Pickett J, Bunn F, Challis D, ... ... Ballard C, et al. Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations. Plos One. 12: e0179521. PMID 28662127 DOI: 10.1371/Journal.Pone.0179521  0.416
2017 Bereczki E, Bogstedt A, Höglund K, Tsitsi P, Brodin L, Ballard C, Svenningsson P, Aarsland D. Synaptic proteins in CSF relate to Parkinson's disease stage markers. Npj Parkinson's Disease. 3: 7. PMID 28649607 DOI: 10.1038/S41531-017-0008-2  0.375
2017 Webster L, Groskreutz D, Grinbergs-Saull A, Howard R, O'Brien JT, Mountain G, Banerjee S, Woods B, Perneczky R, Lafortune L, Roberts C, McCleery J, Pickett J, Bunn F, Challis D, ... ... Ballard C, et al. Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations. Health Technology Assessment (Winchester, England). 21: 1-192. PMID 28625273 DOI: 10.3310/Hta21260  0.371
2017 McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. PMID 28592453 DOI: 10.1212/Wnl.0000000000004058  0.399
2017 Creese B, Bell E, Johar I, Francis P, Ballard C, Aarsland D. Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 28548708 DOI: 10.1002/Ajmg.B.32549  0.375
2017 Khan A, Corbett A, Ballard C. Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets. Expert Review of Neurotherapeutics. PMID 28490260 DOI: 10.1080/14737175.2017.1326818  0.418
2017 Khan A, Corbett A, Ballard C. Emerging amyloid and tau targeting treatments for Alzheimer's disease. Expert Review of Neurotherapeutics. PMID 28490214 DOI: 10.1080/14737175.2017.1326819  0.4
2017 Petyaeva A, Kajander M, Lawrence V, Clifton L, Thomas AJ, Ballard C, Leroi I, Briggs M, Closs J, Dening T, Nunez KM, Testad I, Romeo R, Corbett A. Feasibility of a staff training and support programme to improve pain assessment and management in people with dementia living in care homes. International Journal of Geriatric Psychiatry. PMID 28474837 DOI: 10.1002/Gps.4727  0.305
2017 Mueller C, Ballard C, Corbett A, Aarsland D. Historical landmarks in dementia with Lewy bodies. The Lancet. Neurology. 16: 348. PMID 28414651 DOI: 10.1016/S1474-4422(17)30089-3  0.395
2017 Mueller C, Ballard C, Corbett A, Aarsland D. The prognosis of dementia with Lewy bodies. The Lancet. Neurology. PMID 28342649 DOI: 10.1016/S1474-4422(17)30074-1  0.48
2017 Rajkumar AP, Ballard C, Fossey J, Orrell M, Moniz-Cook E, Woods RT, Murray J, Whitaker R, Stafford J, Knapp M, Romeo R, Woodward-Carlton B, Khan Z, Testad I, Corbett A. Epidemiology of Pain in People With Dementia Living in Care Homes: Longitudinal Course, Prevalence, and Treatment Implications. Journal of the American Medical Directors Association. PMID 28330634 DOI: 10.1016/J.Jamda.2017.01.024  0.343
2017 Ffytche DH, Pereira JB, Ballard C, Chaudhuri KR, Weintraub D, Aarsland D. Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative. Journal of Neurology, Neurosurgery, and Psychiatry. 88: 325-331. PMID 28315846 DOI: 10.1136/Jnnp-2016-314832  0.328
2017 Alghamdi A, Vallortigara J, Howlett DR, Broadstock M, Hortobágyi T, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Attems J, Francis PT, Whitfield DR. Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is associated with Cognitive Impairment in Lewy Body Dementia. Journal of Alzheimer's Disease : Jad. PMID 28269775 DOI: 10.3233/Jad-160946  0.439
2017 Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C. Cognitive decline in Parkinson disease. Nature Reviews. Neurology. PMID 28257128 DOI: 10.1038/Nrneurol.2017.27  0.397
2017 Wesnes KA, Brooker H, Ballard C, McCambridge L, Stenton R, Corbett A. Utility, reliability, sensitivity and validity of an online test system designed to monitor changes in cognitive function in clinical trials. International Journal of Geriatric Psychiatry. PMID 28128869 DOI: 10.1002/Gps.4659  0.301
2017 Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D. The psychosis spectrum in Parkinson disease. Nature Reviews. Neurology. PMID 28106066 DOI: 10.1038/Nrneurol.2016.200  0.305
2017 Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw JM, Ford GA, et al. Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial. Plos One. 12: e0164608. PMID 28095412 DOI: 10.1371/Journal.Pone.0164608  0.321
2017 Ballard C. Psychotic Episodes in Alzheimer’s Disease European Neurological Review. 12: 60. DOI: 10.17925/Enr.2017.12.02.60  0.301
2017 Husebø BS, Ballard C, Cohen-Mansfield J, Aarsland D. The Response Of Agitated Behavior To Pain Management In Persons With Dementia. Rct Trial Innovation in Aging. 1: 21-22. DOI: 10.1093/Geroni/Igx004.083  0.31
2017 Ballard C, Fossey J, Corbett A, Orrell M, Romeo R, Moniz-Cook E, Woods B, Whitaker R. Impact of WHELD intervention on neuropsychiatric symptoms, antipsychotic use and quality of life in people with dementia living in nursing homes: a cluster- randomized trial Alzheimers & Dementia. 13: 171. DOI: 10.1016/J.Jalz.2017.07.011  0.319
2017 Hortobagyi T, Alghamdi A, Whitfield D, Vallortigara J, Howlett D, Broadstock M, Ballard C, Thomas A, Attems J, Aarsland D, Francis PT. RPT6, 20S α-6 AND α-3 PROTEASOME SUBUNIT LEVELS AND ASSOCIATION WITH COGNITIVE DECLINE IN ALZHEIMER’S DISEASE AND LEWY BODY DEMENTIAS Alzheimers & Dementia. 13: 684. DOI: 10.1016/J.Jalz.2017.06.855  0.353
2017 Wesnes K, Brooker H, Corbett A, McCambridge L, Ballard C. The Association Between Cognitive Function And Activities Of Daily Living In Healthy Adults Aged 50 And Over Alzheimers & Dementia. 13: 532. DOI: 10.1016/J.Jalz.2017.06.630  0.302
2017 Mueller C, Perera G, Rajamani A, Bhattarai M, Stewart R, Ballard C, Aarsland D. Risk And Duration Of Hospitalization In Dementia With Lewy Bodies Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.580  0.33
2017 Rajamani APR, Ballard C, Fossey J, Orrell M, Moniz-Cook E, Woods R, Murray J, Whitaker R, Stafford J, Knapp MRJ, Khan Z, Corbett A. Epidemiology Of Pain In People With Dementia Living In Care Homes: Longitudinal Course, Prevalence And Treatment Implications Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.578  0.343
2017 Creese B, Ballard C, Aarsland D, Bergh S, Rongve A, Selbaek G. AN EVALUATION OF PREDICTORS AND COGNITIVE DECLINE ASSOCIATED WITH PERSISTENT AND TRANSIENT PSYCHOTIC SYMPTOMS IN ALZHEIMER’S DISEASE: 2017 Abstract Supplement Alzheimers & Dementia. 13: 367. DOI: 10.1016/J.Jalz.2017.06.315  0.358
2017 Webster L, Groskreutz D, Grinbergs-Saull A, Howard R, O'Brien JT, Mountain G, Banerjee S, Woods B, Perneczky R, Lafortune L, Roberts C, McCleery J, Pickett J, Bunn F, Challis D, ... ... Ballard C, et al. A Core Outcome Set For Disease Modification Trials In Mild-To-Moderate Dementia: A Systematic Review And Consensus Recommendations Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1883  0.357
2017 Huntley JD, Corbett A, Wesnes K, Hampshire A, Ballard C. [P3-563]: RISK FACTORS FOR DEMENTIA AND COGNITIVE FUNCTION IN HEALTHY ADULTS Alzheimer's & Dementia. 13: P1194-P1195. DOI: 10.1016/J.Jalz.2017.06.1783  0.357
2017 Hortobagyi T, Alghamdi A, Vallortigara J, Whitfield D, Howlett DR, Broadstock M, Ballard C, Attems J, Aarsland D, Francis PT. RELATIONSHIP BETWEEN PATHOLOGY SCORES, CLINICAL DATA AND EXPRESSION LEVELS OF PROTEASOME SUB-UNITS IN ALZHEIMER’S DISEASE AND LEWY BODY DEMENTIAS: 2017 Abstract Supplement Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.055  0.365
2016 Chong JR, Chai YL, Lee JH, Howlett D, Attems J, Ballard CG, Aarsland D, Francis PT, Chen CP, Lai MK. Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load. Journal of Alzheimer's Disease : Jad. PMID 27911312 DOI: 10.3233/Jad-160781  0.383
2016 Romeo R, Knapp M, Salverda S, Orrell M, Fossey J, Ballard C. The cost of care homes for people with dementia in England: a modelling approach. International Journal of Geriatric Psychiatry. PMID 27911013 DOI: 10.1002/Gps.4637  0.308
2016 Knapp M, King D, Romeo R, Adams J, Baldwin A, Ballard C, Banerjee S, Barber R, Bentham P, Brown RG, Burns A, Dening T, Findlay D, Holmes C, Johnson T, et al. Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial). International Journal of Geriatric Psychiatry. PMID 27739182 DOI: 10.1002/Gps.4583  0.405
2016 Lee JH, Francis PT, Ballard CG, Aarsland D, Kalaria RN, Wong PT, Chen CP, Lai MK. Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson's Disease Dementia. Journal of Parkinson's Disease. PMID 27662332 DOI: 10.3233/Jpd-160932  0.343
2016 Ballard C, Orrell M, Sun Y, Moniz-Cook E, Stafford J, Whitaker R, Woods B, Corbett A, Banerjee S, Testad I, Garrod L, Khan Z, Woodward-Carlton B, Wenborn J, Fossey J. Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial. International Journal of Geriatric Psychiatry. PMID 27640872 DOI: 10.1002/Gps.4572  0.347
2016 Xing H, Lim YA, Chong JR, Lee JH, Aarsland D, Ballard CG, Francis PT, Chen CP, Lai MK. Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias. Molecular Brain. 9: 84. PMID 27609071 DOI: 10.1186/S13041-016-0264-9  0.33
2016 Enache D, Fereshtehnejad S-, Kåreholt I, Cermakova P, Garcia-Ptacek S, Johnell K, Religa D, Jelic V, Winblad B, Ballard C, Aarsland D, Fastbom J, Eriksdotter M. Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry Acta Psychiatrica Scandinavica. 134: 430-440. PMID 27586958 DOI: 10.1111/Acps.12630  0.392
2016 Khan A, Kalaria RN, Corbett A, Ballard C. Update on Vascular Dementia. Journal of Geriatric Psychiatry and Neurology. 29: 281-301. PMID 27502303 DOI: 10.1177/0891988716654987  0.389
2016 Rongve A, Ballard C, Aarsland D. Non-Alzheimer Dementias. Journal of Geriatric Psychiatry and Neurology. 29: 247-248. PMID 27502298 DOI: 10.1177/0891988716654982  0.446
2016 Winblad B, Qiu C, Ballard C, Johansson G. Evidence-based prevention and treatment of dementia - Authors' reply. The Lancet. Neurology. PMID 27450477 DOI: 10.1016/S1474-4422(16)30128-4  0.366
2016 Greenan C, Murphy L, Yu LM, Kehoe PG, Coulthard E, Bath P, Stewart R, Jones R, Corbett A, Thomas A, Connelly P, Arrojo F, Canning R, Wallach S, Henderson C, ... ... Ballard C, et al. A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol. Trials. 17: 324. PMID 27430267 DOI: 10.1186/S13063-016-1449-3  0.394
2016 Sultana J, Fontana A, Giorgianni F, Pasqua A, Cricelli C, Spina E, Gambassi G, Ivanovic J, Ferrajolo C, Molokhia M, Ballard C, Sharp S, Sturkenboom M, Trifirò G. The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study. Cns Drugs. PMID 27423216 DOI: 10.1007/S40263-016-0366-Z  0.335
2016 Surr CA, Walwyn RE, Lilley-Kelly A, Cicero R, Meads D, Ballard C, Burton K, Chenoweth L, Corbett A, Creese B, Downs M, Farrin AJ, Fossey J, Garrod L, Graham EH, et al. Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial. Trials. 17: 300. PMID 27341812 DOI: 10.1186/S13063-016-1416-Z  0.349
2016 Aman Y, Pitcher T, Simeoli R, Ballard C, Malcangio M. Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease. Pain. PMID 27306045 DOI: 10.1097/J.Pain.0000000000000644  0.347
2016 Ballard C, Mobley W, Hardy J, Williams G, Corbett A. Dementia in Down's syndrome. The Lancet. Neurology. 15: 622-36. PMID 27302127 DOI: 10.1016/S1474-4422(16)00063-6  0.44
2016 Bereczki E, Francis PT, Howlett D, Pereira JB, Höglund K, Bogstedt A, Cedazo-Minguez A, Baek JH, Hortobágyi T, Attems J, Ballard C, Aarsland D. Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27224930 DOI: 10.1016/J.Jalz.2016.04.005  0.438
2016 Lovestone S, Rossor M, Gallacher J, Ritchie C, Burn D, Hyslop PS, Mackay C, Matthews PM, Ballard C, Georges J. Better together for better dementia research and care. The Lancet. Psychiatry. PMID 27198805 DOI: 10.1016/S2215-0366(16)30090-6  0.34
2016 Rajkumar AP, Ballard C, Fossey J, Corbett A, Woods B, Orrell M, Prakash R, Moniz-Cook E, Testad I. Apathy and Its Response to Antipsychotic Review and Nonpharmacological Interventions in People With Dementia Living in Nursing Homes: WHELD, a Factorial Cluster Randomized Controlled Trial. Journal of the American Medical Directors Association. PMID 27184521 DOI: 10.1016/J.Jamda.2016.04.006  0.339
2016 Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet. Neurology. 15: 455-532. PMID 26987701 DOI: 10.1016/S1474-4422(16)00062-4  0.42
2016 Rongve A, Soennesyn H, Skogseth R, Oesterhus R, Hortobágyi T, Ballard CG, Auestad BH, Aarsland D. Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study Bmj Open. 6. PMID 26928028 DOI: 10.1136/Bmjopen-2015-010357  0.465
2016 Corbett A, Ballard C. Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following firstline non-drug approaches Evidence-Based Medicine. 21: 25. DOI: 10.1136/Ebmed-2015-110324  0.361
2016 Mills R, Ballard C, Isaacson S, Williams H, Corbett A, Coate B, Pahwa R, Rascol O, Burn D. Impact of current antipsychotic medications on comparative mortality and adverse events in people with Parkinson’s disease psychosis (PDP) Parkinsonism & Related Disorders. 22. DOI: 10.1016/J.Parkreldis.2015.10.194  0.321
2016 Aarsland D, Skogseth RE, Chwiszczuk LJ, Sonnesyn H, Rongve A, Ballard C, Hortobagyi T. Clinico-Pathologic Correlations In Dementia With Lewy Bodies (Dlb): A Prospective Cohort Study Alzheimers & Dementia. 12: 291. DOI: 10.1016/J.Jalz.2016.06.525  0.408
2016 Khan Z, Ballard C. Nonverbal Communication And Quality Of Life Of People With Dementia Alzheimers & Dementia. 12: 279. DOI: 10.1016/J.Jalz.2016.06.506  0.301
2016 Ballard C, Fossey J. Wheld: An Rct Of An Optimized Non-Pharmacological Intervention To Improve Agitation And Quality Of Life In 1006 People With Dementia Living In Nursing Homes Alzheimers & Dementia. 12: 599. DOI: 10.1016/J.Jalz.2016.06.1181  0.3
2016 Enache D, Fereshtehnejad SM, Cermakova P, Garcia-Ptacek S, Kåreholt I, Johnell K, Religa D, Jelic V, Winblad B, Ballard C, Aarsland D, Fastbom J, Eriksdotter M. Antidepressants and mortality risk in a dementia cohort – data from SveDem, the Swedish Dementia Registry European Psychiatry. 33. DOI: 10.1016/J.Eurpsy.2016.01.039  0.444
2015 Puangmalai N, Somani A, Thangnipon W, Ballard C, Broadstock M. A genetically immortalized human stem cell line: a promising new tool for Alzheimer's disease therapy. Excli Journal. 14: 1135-14. PMID 27152108 DOI: 10.17179/Excli2015-560  0.343
2015 Vallortigara J, Whitfield D, Quelch W, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, O'Brien JT, Thomas A, Ballard CG, Aarsland D, Francis PT. Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia. Journal of Alzheimer's Disease : Jad. PMID 26639969 DOI: 10.3233/Jad-150707  0.41
2015 Ballard C, Orrell M, YongZhong S, Moniz-Cook E, Stafford J, Whittaker R, Woods B, Corbett A, Garrod L, Khan Z, Woodward-Carlton B, Wenborn J, Fossey J. Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program. The American Journal of Psychiatry. appiajp201515010130. PMID 26585409 DOI: 10.1176/Appi.Ajp.2015.15010130  0.34
2015 Scutt P, Blackburn D, Krishnan K, Ballard C, Burns A, Ford GA, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw JM, Bath PM. Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST). Trials. 16: 509. PMID 26545986 DOI: 10.1186/S13063-015-1033-2  0.343
2015 Corbett A, Owen A, Hampshire A, Grahn J, Stenton R, Dajani S, Burns A, Howard R, Williams N, Williams G, Ballard C. The Effect of an Online Cognitive Training Package in Healthy Older Adults: An Online Randomized Controlled Trial. Journal of the American Medical Directors Association. 16: 990-7. PMID 26543007 DOI: 10.1016/J.Jamda.2015.06.014  0.319
2015 Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, ... ... Ballard C, et al. Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses. The Lancet. Neurology. PMID 26515660 DOI: 10.1016/S1474-4422(15)00258-6  0.385
2015 Ballard C, Sharp S, Corbett A. Dextromethorphan and Quinidine for Treating Agitation in Patients With Alzheimer Disease Dementia. Jama. 314: 1233-5. PMID 26393843 DOI: 10.1001/Jama.2015.10215  0.395
2015 Ballard C, Isaacson S, Mills R, Williams H, Corbett A, Coate B, Pahwa R, Rascol O, Burn DJ. Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis. Journal of the American Medical Directors Association. PMID 26239690 DOI: 10.1016/J.Jamda.2015.06.021  0.333
2015 Brooker DJ, Latham I, Evans SC, Jacobson N, Perry W, Bray J, Ballard C, Fossey J, Pickett J. FITS into practice: translating research into practice in reducing the use of anti-psychotic medication for people with dementia living in care homes. Aging & Mental Health. 1-10. PMID 26167720 DOI: 10.1080/13607863.2015.1063102  0.326
2015 Zuidema SU, Johansson A, Selbaek G, Murray M, Burns A, Ballard C, Koopmans RT. A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice. International Psychogeriatrics / Ipa. 27: 1849-59. PMID 26062126 DOI: 10.1017/S1041610215000745  0.326
2015 Green D, Ballard C, Kunst G. Depth of anaesthesia optimisation and postoperative cognitive dysfunction. British Journal of Anaesthesia. 114: 343-4. PMID 25596221 DOI: 10.1093/Bja/Aeu471  0.306
2015 Ballard C, Thomas A, Gerry S, Yu LM, Aarsland D, Merritt C, Corbett A, Davison C, Sharma N, Khan Z, Creese B, Loughlin P, Bannister C, Burns A, Win SN, et al. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD). Journal of the American Medical Directors Association. 16: 316-22. PMID 25523285 DOI: 10.1016/J.Jamda.2014.11.002  0.39
2015 Howlett DR, Whitfield D, Johnson M, Attems J, O'Brien JT, Aarsland D, Lai MK, Lee JH, Chen C, Ballard C, Hortobágyi T, Francis PT. Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias. Brain Pathology (Zurich, Switzerland). 25: 401-8. PMID 25103200 DOI: 10.1111/Bpa.12182  0.45
2015 Enache D, Cavallin L, Lindberg O, Farahmand B, Kramberger MG, Westman E, Jelic V, Eriksdotter M, Ballard C, Winblad B, Wahlund LO, Aarsland D. Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease. Journal of Geriatric Psychiatry and Neurology. 28: 40-8. PMID 25080472 DOI: 10.1177/0891988714541873  0.388
2015 Ekonomou A, Savva GM, Brayne C, Forster G, Francis PT, Johnson M, Perry EK, Attems J, Somani A, Minger SL, Ballard CG. Stage-specific changes in neurogenic and glial markers in Alzheimer's disease. Biological Psychiatry. 77: 711-9. PMID 25022604 DOI: 10.1016/J.Biopsych.2014.05.021  0.421
2015 Ferreira N, Owen A, Mohan A, Corbett A, Ballard C. Associations between cognitively stimulating leisure activities, cognitive function and age-related cognitive decline. International Journal of Geriatric Psychiatry. 30: 422-30. PMID 24989949 DOI: 10.1002/Gps.4155  0.315
2015 Whitfield DR, Vallortigara J, Alghamdi A, Hortobágyi T, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Francis PT. Depression and synaptic zinc regulation in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 23: 141-8. PMID 24953873 DOI: 10.1016/J.Jagp.2014.05.001  0.371
2015 Bradley P, Akehurst R, Ballard C, Banerjee S, Blennow K, Bremner J, Broich K, Cummings J, Dening K, Dubois B, Klipper W, Leibman C, Mantua V, Molinuevo JL, Morgan S, et al. Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 455-61. PMID 24751826 DOI: 10.1016/J.Jalz.2014.01.007  0.345
2015 Wesnes KA, Aarsland D, Ballard C, Londos E. Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies International Journal of Geriatric Psychiatry. 30: 46-54. PMID 24737460 DOI: 10.1002/Gps.4109  0.384
2015 Corbett AMJ, Williams G, Ballard CG. Drug repositioning in Alzheimer's disease. Frontiers in Bioscience. 7: 184-188. DOI: 10.2741/S432  0.324
2014 Ruiz A, Hernández I, Ronsende-Roca M, González-Pérez A, Rodriguez-Noriega E, Ramírez-Lorca R, Mauleón A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayán J, Becker JT, Real LM, ... ... Ballard C, et al. Erratum to "Exploratory analysis of seven Alzheimer's disease genes: disease progression" [Neurobiol. Aging 34 (2013) 1310.e1-1310.e7]. Neurobiology of Aging. 35: 2661. PMID 28911722 DOI: 10.1016/J.Neurobiolaging.2014.06.016  0.315
2014 Mok KY, Jones EL, Hanney M, Harold D, Sims R, Williams J, Ballard C, Hardy J. Erratum to "Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome" [Neurobiol. Aging 35 (2014) 1513.e1-1513.e5]. Neurobiology of Aging. 35: 2659. PMID 28911720 DOI: 10.1016/J.Neurobiolaging.2014.06.017  0.327
2014 Khan Z, Corbett A, Ballard C. Cognitive stimulation therapy: training, maintenance and implementation in clinical trials. Pragmatic and Observational Research. 5: 15-19. PMID 27774025 DOI: 10.2147/POR.S56000  0.313
2014 Vallortigara J, Rangarajan S, Whitfield D, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, Ballard C, Thomas A, O'Brien J, Aarsland D, Francis P. Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. F1000research. 3: 108. PMID 25671083 DOI: 10.12688/F1000Research.3786.1  0.452
2014 Corbett A, Burns A, Ballard C. Don't use antipsychotics routinely to treat agitation and aggression in people with dementia. Bmj (Clinical Research Ed.). 349: g6420. PMID 25368388 DOI: 10.1136/Bmj.G6420  0.388
2014 Creese B, Corbett A, Jones E, Fox C, Ballard C. Role of the extended MAPT haplotype in the worsening of psychotic symptoms and treatment response in Alzheimer disease. Journal of the American Medical Directors Association. 15: 934-7. PMID 25306292 DOI: 10.1016/J.Jamda.2014.08.011  0.434
2014 Broadstock M, Ballard C, Corbett A. Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease. Expert Review of Clinical Pharmacology. 7: 779-86. PMID 25301532 DOI: 10.1586/17512433.2014.966814  0.305
2014 Soto M, Andrieu S, Nourhashemi F, Ousset PJ, Ballard C, Robert P, Vellas B, Lyketsos CG, Rosenberg PB. Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design. International Psychogeriatrics / Ipa. 1-17. PMID 25226218 DOI: 10.1017/S1041610214001720  0.36
2014 Whitfield DR, Vallortigara J, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, Newhouse S, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Francis PT. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment. Neurobiology of Aging. 35: 2836-44. PMID 25104558 DOI: 10.1016/J.Neurobiolaging.2014.06.015  0.429
2014 Whitaker R, Fossey J, Ballard C, Orrell M, Moniz-Cook E, Woods RT, Murray J, Stafford J, Knapp M, Romeo R, Carlton BW, Testad I, Khan Z. Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trial. Trials. 15: 284. PMID 25016303 DOI: 10.1186/1745-6215-15-284  0.344
2014 Stubendorff K, Larsson V, Ballard C, Minthon L, Aarsland D, Londos E. Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study Bmj Open. 4: 5158-5158. PMID 24993765 DOI: 10.1136/Bmjopen-2014-005158  0.384
2014 Broadstock M, Ballard C, Corbett A. Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies. Expert Opinion On Pharmacotherapy. 15: 1797-810. PMID 24992196 DOI: 10.1517/14656566.2014.936848  0.449
2014 Ballard C, Corbett A, Howard R. Prescription of antipsychotics in people with dementia. The British Journal of Psychiatry : the Journal of Mental Science. 205: 4-5. PMID 24986385 DOI: 10.1192/Bjp.Bp.113.128710  0.342
2014 Stewart R, Hotopf M, Dewey M, Ballard C, Bisla J, Calem M, Fahmy V, Hockley J, Kinley J, Pearce H, Saraf A, Begum A. Current prevalence of dementia, depression and behavioural problems in the older adult care home sector: the South East London Care Home Survey. Age and Ageing. 43: 562-7. PMID 24855111 DOI: 10.1093/Ageing/Afu062  0.381
2014 Sandvik RK, Selbaek G, Seifert R, Aarsland D, Ballard C, Corbett A, Husebo BS. Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial. European Journal of Pain (London, England). 18: 1490-500. PMID 24819710 DOI: 10.1002/Ejp.523  0.305
2014 Husebø BS, Ballard C, Fritze F, Sandvik RK, Aarsland D. Efficacy of pain treatment on mood syndrome in patients with dementia: a randomized clinical trial International Journal of Geriatric Psychiatry. 29: 828-836. PMID 24806873 DOI: 10.1002/Gps.4063  0.331
2014 Oesterhus R, Soennesyn H, Rongve A, Ballard C, Aarsland D, Vossius C. Long-term mortality in a cohort of home-dwelling elderly with mild Alzheimer's disease and Lewy body dementia. Dementia and Geriatric Cognitive Disorders. 38: 161-169. PMID 24732348 DOI: 10.1159/000358051  0.442
2014 Corbett A, Ballard C. The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs. Evidence-Based Medicine. 19: 140. PMID 24639394 DOI: 10.1136/Eb-2014-101741  0.372
2014 Sultana J, Chang CK, Hayes RD, Broadbent M, Stewart R, Corbett A, Ballard C. Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. International Journal of Geriatric Psychiatry. 29: 1249-54. PMID 24633896 DOI: 10.1002/Gps.4101  0.377
2014 Wimo A, Ballard C, Brayne C, Gauthier S, Handels R, Jones RW, Jonsson L, Khachaturian AS, Kramberger M. Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria. Journal of Internal Medicine. 275: 304-16. PMID 24605810 DOI: 10.1111/Joim.12167  0.405
2014 Testad I, Corbett A, Aarsland D, Lexow KO, Fossey J, Woods B, Ballard C. The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review. International Psychogeriatrics / Ipa. 26: 1083-98. PMID 24565226 DOI: 10.1017/S1041610214000131  0.33
2014 Mulugeta E, Vallortigara J, Francis PT, Hye A, Kalaria RN, Perry EK, Lovestone S, Ballard CG. Dynamin protein in stroke and vascular dementia. Neuroscience Letters. 563: 118-22. PMID 24486840 DOI: 10.1016/J.Neulet.2014.01.045  0.398
2014 Mok KY, Jones EL, Hanney M, Harold D, Sims R, Williams J, Ballard C, Hardy J. Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome. Neurobiology of Aging. 35: 1513.e1-5. PMID 24462566 DOI: 10.1016/J.Neurobiolaging.2013.12.022  0.38
2014 Cummings J, Isaacson S, Mills R, Williams H, Chi-Burris K, Corbett A, Dhall R, Ballard C. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet (London, England). 383: 533-40. PMID 24183563 DOI: 10.1016/S0140-6736(13)62106-6  0.356
2014 Langballe EM, Engdahl B, Nordeng H, Ballard C, Aarsland D, Selbæk G. Short- and Long-term Mortality Risk Associated with the Use of Antipsychotics Among 26,940 Dementia Outpatients: A Population-Based Study American Journal of Geriatric Psychiatry. 22: 321-331. PMID 24016844 DOI: 10.1016/J.Jagp.2013.06.007  0.321
2014 Lebedev AV, Beyer MK, Fritze F, Westman E, Ballard C, Aarsland D. Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 4-13.e1. PMID 23880336 DOI: 10.1016/J.Jagp.2013.02.004  0.395
2014 Mohamed NE, Howlett DR, Ma L, Francis PT, Aarsland D, Ballard CG, McKeith IG, Chen CP, Lai MK. Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 71-8. PMID 23846847 DOI: 10.1007/S00702-013-1067-0  0.442
2014 Lawrence V, Pickett J, Ballard C, Murray J. Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairment. International Journal of Geriatric Psychiatry. 29: 22-31. PMID 23649902 DOI: 10.1002/Gps.3958  0.366
2014 Husebo BS, Ballard C, Cohen-Mansfield J, Seifert R, Aarsland D. The response of agitated behavior to pain management in persons with dementia. American Journal of Geriatric Psychiatry. 22: 708-717. PMID 23611363 DOI: 10.1016/J.Jagp.2012.12.006  0.3
2014 Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E. Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementias. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 580-6. PMID 23582751 DOI: 10.1016/J.Jagp.2012.11.001  0.457
2014 Testad I, Corbett AMJ, Aarsland D, Lexow KO, Fossey J, Woods B, Ballard CG. The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review – CORRIGENDUM International Psychogeriatrics. 26: 1099-1099. DOI: 10.1017/S1041610214000696  0.345
2014 Zuidema SU, Johansson A, Selbæk G, Ballard C, Koopmans RTCM. IS1.07: A consensus guideline for antipsychotic drug use for dementia in long-term care. Collecting expert opinion through Delphi-consensus and focus groups European Geriatric Medicine. 5. DOI: 10.1016/S1878-7649(14)70007-5  0.315
2014 Ballard C, Mills R, Williams H, Corbett A, Cummings J. Treatment of Psychosis in Parkinson's disease and Parkinson's disease dementia Neurobiology of Aging. 35. DOI: 10.1016/J.Neurobiolaging.2014.01.035  0.376
2014 Gatt AP, Jones EL, Francis PT, Ballard C, Bateman JM. Corrigendum to Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies [Neurosci. Lett., 557, (2013), 177-180] Neuroscience Letters. 563: 44. DOI: 10.1016/J.Neulet.2014.01.048  0.397
2014 Bereczki E, Hoglund K, Svenningsson P, Cedazo-Minguez A, Francis P, Ballard CG, Aarsland D. P2-123: BIOMARKERS FOR COGNITIVE DECLINE OF EARLY PARKINSON's DISEASE Alzheimer's & Dementia. 10: P516-P516. DOI: 10.1016/J.Jalz.2014.05.798  0.365
2013 Corbett A, Williams G, Ballard C. Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease. Pharmaceuticals (Basel, Switzerland). 6: 1304-21. PMID 24275851 DOI: 10.3390/Ph6101304  0.356
2013 Blackburn DJ, Krishnan K, Fox L, Ballard C, Burns A, Ford GA, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw J, Bath PM. Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids. Trials. 14: 401. PMID 24266960 DOI: 10.1186/1745-6215-14-401  0.34
2013 Gatt AP, Jones EL, Francis PT, Ballard C, Bateman JM. Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies. Neuroscience Letters. 557: 177-80. PMID 24184878 DOI: 10.1016/J.Neulet.2013.10.045  0.348
2013 Ballard C, O'Sullivan MJ. Alzheimer disease and stroke: Cognitive and neuroimaging predictors of AD and stroke. Nature Reviews. Neurology. 9: 605-6. PMID 24145371 DOI: 10.1038/Nrneurol.2013.215  0.366
2013 Ballard C, Grimmer T. Improving diagnosis of possible DLB Is there a role for MIBG myocardial scintigraphy Neurology. 81: 1730-1731. PMID 24122184 DOI: 10.1212/01.Wnl.0000435567.38352.Ca  0.384
2013 Nordberg A, Ballard C, Bullock R, Darreh-Shori T, Somogyi M. A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. The Primary Care Companion For Cns Disorders. 15. PMID 23930233 DOI: 10.4088/Pcc.12R01412  0.39
2013 Corbett A, Ballard C. Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms? Expert Opinion On Investigational Drugs. 22: 941-3. PMID 23808708 DOI: 10.1517/13543784.2013.815723  0.349
2013 Ballard C, Aarsland D, Francis P, Corbett A. Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management. Drugs & Aging. 30: 603-11. PMID 23681401 DOI: 10.1007/S40266-013-0092-X  0.402
2013 Jones EL, Mok K, Hanney M, Harold D, Sims R, Williams J, Ballard C. Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome. Neurobiology of Aging. 34: 2441.e1-5. PMID 23601808 DOI: 10.1016/J.Neurobiolaging.2013.03.018  0.35
2013 Siepel FJ, Rongve A, Buter TC, Beyer MK, Ballard CG, Booij J, Aarsland D. (123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study. Bmj Open. 3. PMID 23572198 DOI: 10.1136/Bmjopen-2013-002642  0.391
2013 Geda YE, Schneider LS, Gitlin LN, Miller DS, Smith GS, Bell J, Evans J, Lee M, Porsteinsson A, Lanctôt KL, Rosenberg PB, Sultzer DL, Francis PT, Brodaty H, Padala PP, ... ... Ballard C, et al. Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 602-8. PMID 23562430 DOI: 10.1016/J.Jalz.2012.12.001  0.375
2013 Ballard C, Corbett A. Agitation and aggression in people with Alzheimer's disease. Current Opinion in Psychiatry. 26: 252-9. PMID 23528917 DOI: 10.1097/Yco.0B013E32835F414B  0.378
2013 Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, et al. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technology Assessment (Winchester, England). 17: 1-166. PMID 23438937 DOI: 10.3310/Hta17070  0.38
2013 Creese B, Ballard C, Jones E. Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic review. Dementia and Geriatric Cognitive Disorders. 35: 155-64. PMID 23392273 DOI: 10.1159/000346733  0.424
2013 Ballard C, Francis P, Corbett A. Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies. International Psychogeriatrics / Ipa. 25: 687-9. PMID 23347752 DOI: 10.1017/S1041610213000033  0.314
2013 Whitaker R, Ballard C, Stafford J, Orrell M, Moniz-Cook E, Woods RT, Murray J, Knapp M, Carlton BW, Fossey J. Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trial. Trials. 14: 13. PMID 23305152 DOI: 10.1186/1745-6215-14-13  0.334
2013 Romeo R, Knapp M, Hellier J, Dewey M, Ballard C, Baldwin R, Bentham P, Burns A, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, et al. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. The British Journal of Psychiatry : the Journal of Mental Science. 202: 121-8. PMID 23258767 DOI: 10.1192/Bjp.Bp.112.115212  0.332
2013 Ruiz A, Hernández I, Ronsende-Roca M, González-Pérez A, Rodriguez-Noriega E, Ramírez-Lorca R, Mauleón A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayán J, Becker JT, Real LM, ... ... Ballard C, et al. Exploratory analysis of seven Alzheimer's disease genes: disease progression. Neurobiology of Aging. 34: 1310.e1-7. PMID 23036585 DOI: 10.1016/J.Neurobiolaging.2012.08.014  0.376
2013 Ballard C, Corbett A. A small proportion of people with dementia and neuropsychiatric symptoms experience clinically significant worsening when antidepressants are discontinued. Evidence-Based Medicine. 18: 27-8. PMID 22951815 DOI: 10.1136/Eb-2012-100735  0.41
2013 Vallortigara J, Quelch W, Hortobagyi T, Attems J, O'Brien J, Thomas A, Ballard CG, Aarsland D, Francis PT. Synaptic dysfunction and correlations with clinico-pathological features in dementia with Lewy bodies and Parkinson's disease dementia F1000research. 4. DOI: 10.7490/F1000Research.1094082.1  0.422
2013 Wesnes K, Aarsland D, Ballard C, Londos E. Memantine improves attention and verbal episodic memory in Parkinson's disease dementia and dementia with Lewy bodies: A double-blind, placebo-controlled multicentre trial Alzheimers & Dementia. 9: 890. DOI: 10.1016/J.Jalz.2013.08.252  0.31
2013 Francis P, Hortobágyi T, Attems J, Aarsland D, Ballard C, O'Brein J, Whitfield D, Alghamdi A, Vallortigara J. P3-041: Contribution of Alzheimer's disease and Lewy body pathology to behavior and cognition in Lewy body dementias Alzheimer's & Dementia. 9: P566-P566. DOI: 10.1016/J.Jalz.2013.05.1110  0.434
2012 Jones EL, Gauge N, Nilsen OB, Lowery D, Wesnes K, Katsaiti E, Arden J, Amoako D, Prophet N, Purushothaman B, Green D, Ballard C. Analysis of neuron-specific enolase and S100B as biomarkers of cognitive decline following surgery in older people. Dementia and Geriatric Cognitive Disorders. 34: 307-11. PMID 23208248 DOI: 10.1159/000345538  0.319
2012 Corbett A, Pickett J, Burns A, Corcoran J, Dunnett SB, Edison P, Hagan JJ, Holmes C, Jones E, Katona C, Kearns I, Kehoe P, Mudher A, Passmore A, Shepherd N, ... ... Ballard C, et al. Drug repositioning for Alzheimer's disease. Nature Reviews. Drug Discovery. 11: 833-46. PMID 23123941 DOI: 10.1038/Nrd3869  0.367
2012 Lawrence V, Fossey J, Ballard C, Moniz-Cook E, Murray J. Improving quality of life for people with dementia in care homes: making psychosocial interventions work. British Journal of Psychiatry. 201: 344-351. PMID 23118034 DOI: 10.1192/Bjp.Bp.111.101402  0.334
2012 Ballard C, Corbett A. Dementia: new guidelines on disorders associated with dementia. Nature Reviews. Neurology. 8: 663-4. PMID 23093329 DOI: 10.1038/Nrneurol.2012.221  0.43
2012 Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E. No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias. Neuroscience Letters. 531: 1-4. PMID 23069674 DOI: 10.1016/J.Neulet.2012.09.062  0.454
2012 Aarsland D, Ballard CG. Biomarkers for dementia diagnosis: differentiating DLB and FTD may be difficult. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 1037. PMID 22869920 DOI: 10.1136/Jnnp-2012-303026  0.44
2012 Bjoerke-Bertheussen J, Ehrt U, Rongve A, Ballard C, Aarsland D. Neuropsychiatric symptoms in mild dementia with lewy bodies and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 34: 1-6. PMID 22854420 DOI: 10.1159/000339590  0.43
2012 Svenningsson P, Westman E, Ballard C, Aarsland D. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. The Lancet. Neurology. 11: 697-707. PMID 22814541 DOI: 10.1016/S1474-4422(12)70152-7  0.454
2012 Aarsland D, Ballard C, Rongve A, Broadstock M, Svenningsson P. Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia. Current Neurology and Neuroscience Reports. 12: 492-501. PMID 22806065 DOI: 10.1007/S11910-012-0290-7  0.462
2012 Fox C, Crugel M, Maidment ID, Auestad BH, Coulton S, Treloar A, Ballard CG, Boustani M, Katona C, Livingston G. Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial Plos One. 7. PMID 22567095 DOI: 10.1371/Journal.Pone.0035185  0.408
2012 Corbett A, Smith J, Ballard C. New and emerging treatments for Alzheimer's disease. Expert Review of Neurotherapeutics. 12: 535-43. PMID 22550982 DOI: 10.1586/Ern.12.43  0.403
2012 Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J. Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiology of Disease. 47: 155-62. PMID 22504537 DOI: 10.1016/J.Nbd.2012.03.033  0.339
2012 Corbett A, Husebo B, Malcangio M, Staniland A, Cohen-Mansfield J, Aarsland D, Ballard C. Assessment and treatment of pain in people with dementia. Nature Reviews. Neurology. 8: 264-74. PMID 22487749 DOI: 10.1038/Nrneurol.2012.53  0.334
2012 Corbett A, Ballard C. New and emerging treatments for Alzheimer's disease. Expert Opinion On Emerging Drugs. 17: 147-56. PMID 22439621 DOI: 10.1517/14728214.2012.675327  0.409
2012 Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Hughes A, Jacoby R, Jones R, Jones R, McKeith I, ... ... Ballard C, et al. Donepezil and memantine for moderate-to-severe Alzheimer's disease. The New England Journal of Medicine. 366: 893-903. PMID 22397651 DOI: 10.1056/Nejmoa1106668  0.368
2012 Corbett A, Smith J, Creese B, Ballard C. Treatment of behavioral and psychological symptoms of Alzheimer's disease. Current Treatment Options in Neurology. 14: 113-25. PMID 22328204 DOI: 10.1007/S11940-012-0166-9  0.408
2012 Jones EL, Aarsland D, Londos E, Ballard C. A pilot study examining associations between DYRK1A and α-synuclein dementias. Neuro-Degenerative Diseases. 10: 229-31. PMID 22269890 DOI: 10.1159/000334759  0.403
2012 Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu LM, Tyrer S, Francis PT, Johnson T, Bullock R, Ballard C. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet. 379: 528-36. PMID 22236802 DOI: 10.1016/S0140-6736(11)61676-0  0.419
2012 Corbett A, Ballard C. Antipsychotics and mortality in dementia. The American Journal of Psychiatry. 169: 7-9. PMID 22223007 DOI: 10.1176/Appi.Ajp.2011.11101488  0.337
2012 Corbett A, Stevens J, Aarsland D, Day S, Moniz-Cook E, Woods R, Brooker D, Ballard C. Systematic review of services providing information and/or advice to people with dementia and/or their caregivers. International Journal of Geriatric Psychiatry. 27: 628-36. PMID 22038644 DOI: 10.1002/Gps.2762  0.336
2012 Ekonomou A, Johnson M, Perry RH, Perry EK, Kalaria RN, Minger SL, Ballard CG. Increased neural progenitors in individuals with cerebral small vessel disease. Neuropathology and Applied Neurobiology. 38: 344-53. PMID 21988073 DOI: 10.1111/J.1365-2990.2011.01224.X  0.378
2012 Ballard C. 4 Optimal treatment for parkinson patients with cognitive disorders Neurobiology of Aging. 33. DOI: 10.1016/J.Neurobiolaging.2012.01.022  0.3
2012 Ballard C, Aarsland D, Walker Z, Thomas A. A randomized double blind clinical trial comparing memantine and antipsychotics for the prophylaxis of behavioural and psychological symptoms in people with Alzheimer's disease (MAIN AD) Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2013.08.027  0.415
2012 Ballard C. Behavioral alternatives to anti-psychotic prescribing for people with dementia in residential care settings Alzheimers & Dementia. 8: 230. DOI: 10.1016/J.Jalz.2012.05.607  0.333
2012 Ruiz A, Hernandez I, Rosende-Roca M, González-Pérez A, Rodríguez-Noriega E, Ramirez-Lorca R, Mauleon A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayán J, Becker J, Real LM, ... ... Ballard C, et al. Exploratory analysis of seven confirmed risk factors for Alzheimer's disease with disease progression Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.2108  0.346
2012 Corbett A, Burns A, Ballard C. Management of behavioural and psychological symptoms of dementia: Development of a best practice guide Alzheimers & Dementia. 8: 609. DOI: 10.1016/J.Jalz.2012.05.1632  0.336
2012 Ballard C, Fossey J, Stafford J, Testad I. Psychological interventions for neuropsychiatric symptoms in dementia Alzheimers & Dementia. 8: 609. DOI: 10.1016/J.Jalz.2012.05.1631  0.354
2011 Auning E, Rongve A, Fladby T, Booij J, Hortobágyi T, Siepel FJ, Ballard C, Aarsland D. Early and presenting symptoms of dementia with lewy bodies. Dementia and Geriatric Cognitive Disorders. 32: 202-8. PMID 22095040 DOI: 10.1159/000333072  0.419
2011 Ballard C, Smith J, Husebo B, Aarsland D, Corbett A. The role of pain treatment in managing the behavioural and psychological symptoms of dementia (BPSD). International Journal of Palliative Nursing. 17: 420, 422, 424. PMID 22067732 DOI: 10.12968/Ijpn.2011.17.9.420  0.384
2011 Ballard C, Khan Z, Clack H, Corbett A. Nonpharmacological treatment of Alzheimer disease. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 56: 589-95. PMID 22014691 DOI: 10.1177/070674371105601004  0.417
2011 Fritze F, Ehrt U, Hortobagyi T, Ballard C, Aarsland D. Depressive symptoms in Alzheimer's disease and lewy body dementia: a one-year follow-up study. Dementia and Geriatric Cognitive Disorders. 32: 143-149. PMID 21986003 DOI: 10.1159/000332016  0.38
2011 Ballard C, Kahn Z, Corbett A. Treatment of Dementia with Lewy Bodies and Parkinson’s Disease Dementia Drugs & Aging. 28: 769-777. PMID 21970305 DOI: 10.2165/11594110-000000000-00000  0.473
2011 Mulugeta E, Londos E, Hansson O, Ballard C, Skogseth R, Minthon L, Blennow K, Zetterberg H, Aarsland D. Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates. International Journal of Alzheimer's Disease. 2011: 495025. PMID 21966597 DOI: 10.4061/2011/495025  0.418
2011 Ballard C, Corbett A. Screening for dementia: an opportunity for debate. Expert Review of Neurotherapeutics. 11: 1347-1349. PMID 21955189 DOI: 10.1586/Ern.11.121  0.339
2011 Fritze F, Ehrt U, Sønnesyn H, Kurz M, Hortobágyi T, Nore SP, Ballard C, Aarsland D. Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features. International Journal of Geriatric Psychiatry. 26: 1054-61. PMID 21905099 DOI: 10.1002/Gps.2643  0.367
2011 Corbett A, Ballard C. Information provision services in dementia care. International Journal of Older People Nursing. 6: 217-226. PMID 21884487 DOI: 10.1111/J.1748-3743.2011.00289.X  0.363
2011 Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. Bmj (Clinical Research Ed.). 343: d4065. PMID 21765198 DOI: 10.1136/Bmj.D4065  0.328
2011 Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet (London, England). 378: 403-11. PMID 21764118 DOI: 10.1016/S0140-6736(11)60830-1  0.359
2011 Sharp SI, Aarsland D, Day S, Sønnesyn H, Ballard C. Hypertension is a potential risk factor for vascular dementia: systematic review. International Journal of Geriatric Psychiatry. 26: 661-9. PMID 21495075 DOI: 10.1002/Gps.2572  0.332
2011 Jones EL, Kalaria RN, Sharp SI, O'Brien JT, Francis PT, Ballard CG. Genetic associations of autopsy-confirmed vascular dementia subtypes. Dementia and Geriatric Cognitive Disorders. 31: 247-53. PMID 21474934 DOI: 10.1159/000327171  0.382
2011 Ballard C, Corbett A, Sharp S. Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer’s disease Expert Review of Neurotherapeutics. 11: 327-329. PMID 21375436 DOI: 10.1586/Ern.11.13  0.36
2011 Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 377: 1019-31. PMID 21371747 DOI: 10.1016/S0140-6736(10)61349-9  0.324
2011 Burns A, Perry E, Holmes C, Francis P, Morris J, Howes MJ, Chazot P, Lees G, Ballard C. A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 31: 158-64. PMID 21335973 DOI: 10.1159/000324438  0.383
2011 Clarke NA, Hartmann T, Jones EL, Ballard CG, Francis PT. Antipsychotic medication is associated with selective alterations in ventricular cerebrospinal fluid Aβ 40 and tau in patients with intractable unipolar depression. International Journal of Geriatric Psychiatry. 26: 1283-91. PMID 21308788 DOI: 10.1002/Gps.2678  0.308
2011 Husebo BS, Ballard C, Aarsland D. Pain treatment of agitation in patients with dementia: a systematic review. International Journal of Geriatric Psychiatry. 26: 1012-1018. PMID 21308784 DOI: 10.1002/Gps.2649  0.339
2011 Ballard C, Corbett A, Jones EL. Dementia: challenges and promising developments. The Lancet. Neurology. 10: 7-9. PMID 21163436 DOI: 10.1016/S1474-4422(10)70304-5  0.401
2011 Mulugeta E, Londos E, Ballard C, Alves G, Zetterberg H, Blennow K, Skogseth R, Minthon L, Aarsland D. CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 160-4. PMID 21047883 DOI: 10.1136/Jnnp.2009.199398  0.387
2011 Howard R, Phillips P, Johnson T, O'Brien J, Sheehan B, Lindesay J, Bentham P, Burns A, Ballard C, Holmes C, McKeith I, Barber R, Dening T, Ritchie C, Jones R, et al. Determining the minimum clinically important differences for outcomes in the DOMINO trial. International Journal of Geriatric Psychiatry. 26: 812-7. PMID 20848576 DOI: 10.1002/Gps.2607  0.32
2011 Morris CM, Ballard CG, Allan L, Rowan E, Stephens S, Firbank M, Ford GA, Kenny RA, O'Brien JT, Kalaria RN. NOS3 gene rs1799983 polymorphism and incident dementia in elderly stroke survivors. Neurobiology of Aging. 32: 554.e1-6. PMID 20691505 DOI: 10.1016/J.Neurobiolaging.2010.06.012  0.348
2011 Ballard C, Creese B, Corbett A, Aarsland D. Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality. Expert Opinion On Drug Safety. 10: 35-43. PMID 20684745 DOI: 10.1517/14740338.2010.506711  0.37
2011 Johnson M, Ekonomou A, Hobbs C, Ballard CG, Perry RH, Perry EK. Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies. Hippocampus. 21: 1126-36. PMID 20665591 DOI: 10.1002/Hipo.20826  0.339
2011 Johansson C, Ballard C, Hansson O, Palmqvist S, Minthon L, Aarsland D, Londos E. Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment. International Journal of Geriatric Psychiatry. 26: 206-13. PMID 20665553 DOI: 10.1002/Gps.2516  0.385
2011 Ekonomou A, Ballard CG, Pathmanaban ON, Perry RH, Perry EK, Kalaria RN, Minger SL. Increased neural progenitors in vascular dementia. Neurobiology of Aging. 32: 2152-61. PMID 20138403 DOI: 10.1016/J.Neurobiolaging.2010.01.007  0.328
2011 Fox C, Boustani M, Crugel M, Maidment I, Ballard C, Katona C, Livingston G, Adrian T, Coulton S, Mcshane R. MAGD Trial-Memantine for Agitation in Alzheimer's Dementia Journal of the American Geriatrics Society. 59. DOI: 10.1111/J.1532-5415.2011.03416.X  0.432
2011 Fox C, Crugel M, McShane R, Boustani M, Katona C, Maidment I, Ballard C, Treloar A, Livingston G, Coulton S. Memantine for agitation in dementia Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.09.110  0.449
2011 Fox C, Maidment I, Crugel M, Katona C, Livingston G, Ballard C, McShane R, Boustani M, Treloar A, Coulton S. Randomized controlled trial of memantine for agitation in dementia Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.09.109  0.352
2011 Vallortigara J, Warren F, Ballard C, Boess F, Aarsland D, Targett M, Alghamdi A, Francis P. Impairment of the proteasome on frontal cortex in lewy body dementia Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2199  0.367
2011 Rognve A, Auning E, Fladby T, Ballard C, Aarsland D. The pre-dementia stage of dementia with Lewy bodies Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2151  0.408
2010 Jones EL, Ballard CG, Prasher VP, Arno M, Tyrer S, Moore B, Hanney ML. An Intron 7 Polymorphism in APP Affects the Age of Onset of Dementia in Down Syndrome. International Journal of Alzheimer's Disease. 2011: 929102. PMID 21197396 DOI: 10.4061/2011/929102  0.395
2010 Kirvell SL, Elliott MS, Kalaria RN, Hortobágyi T, Ballard CG, Francis PT. Vesicular glutamate transporter and cognition in stroke: a case-control autopsy study. Neurology. 75: 1803-9. PMID 21079182 DOI: 10.1212/Wnl.0B013E3181Fd6328  0.388
2010 Ballard CG, Jones EL. CSF α-synuclein as a diagnostic biomarker for Parkinson disease and related dementias. Neurology. 75: 1760-1. PMID 20962288 DOI: 10.1212/Wnl.0B013E3181Fd6393  0.366
2010 Larsson V, Aarsland D, Ballard C, Minthon L, Londos E. The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia. International Journal of Geriatric Psychiatry. 25: 1030-1038. PMID 20872929 DOI: 10.1002/Gps.2506  0.307
2010 Ballard C, Corbett A. Management of Neuropsychiatric Symptoms in People with Dementia Cns Drugs. 24: 729-739. PMID 20806986 DOI: 10.2165/11319240-000000000-00000  0.393
2010 Vernon AC, Ballard C, Modo M. Neuroimaging for Lewy body disease: Is the in vivo molecular imaging of ?-synuclein neuropathology required and feasible? Brain Research Reviews. 65: 28-55. PMID 20685363 DOI: 10.1016/J.Brainresrev.2010.05.006  0.352
2010 Alves G, Brønnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C, Kurz MW, Andreasson U, Tysnes OB, Larsen JP, Mulugeta E. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 1080-6. PMID 20547614 DOI: 10.1136/Jnnp.2009.199950  0.37
2010 Aarsland D, Sardahaee FS, Anderssen S, Ballard C. Is physical activity a potential preventive factor for vascular dementia? A systematic review Aging & Mental Health. 14: 386-395. PMID 20455113 DOI: 10.1080/13607860903586136  0.355
2010 Rongve A, Brønnick K, Ballard C, Aarsland D. Core and suggestive symptoms of dementia with lewy bodies cluster in persons with mild dementia. Dementia and Geriatric Cognitive Disorders. 29: 317-324. PMID 20389073 DOI: 10.1159/000295111  0.401
2010 Testad I, Ballard C, Brønnick K, Aarsland D. The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial. The Journal of Clinical Psychiatry. 71: 80-86. PMID 20129008 DOI: 10.4088/Jcp.09M05486Oli  0.323
2010 Gauthier S, Cummings J, Ballard C, Brodaty H, Grossberg G, Robert P, Lyketsos C. Management of behavioral problems in Alzheimer's disease. International Psychogeriatrics / Ipa. 22: 346-72. PMID 20096151 DOI: 10.1017/S1041610209991505  0.407
2010 Lowery DP, Wesnes K, Brewster N, Ballard C. Subtle deficits of attention after surgery: quantifying indicators of sub syndrome delirium International Journal of Geriatric Psychiatry. 25: 945-952. PMID 20054840 DOI: 10.1002/Gps.2430  0.318
2010 Ehrt U, Broich K, Larsen JP, Ballard C, Aarsland D. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study Journal of Neurology, Neurosurgery, and Psychiatry. 81: 160-165. PMID 19770163 DOI: 10.1136/Jnnp.2009.186239  0.348
2010 Ballard C, Jones EL, Londos E, Minthon L, Francis P, Aarsland D. alpha-Synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies. International Psychogeriatrics / Ipa. 22: 321-7. PMID 19747426 DOI: 10.1017/S1041610209991049  0.339
2010 Rongve A, Brønnick K, Ballard C, Aarsland D. PW01-89 - Symtoms of dementia with lewy bodies cluster in persons with mild dementia European Psychiatry. 25: 1505. DOI: 10.1016/S0924-9338(10)71488-7  0.384
2010 Rongve A, Nilsen OB, Ballard C, Aarsland D. P01-371 - Shorter time until nursing home admission in lewy body dementias as compared to Alzheimer's dementia European Psychiatry. 25: 584. DOI: 10.1016/S0924-9338(10)70579-4  0.398
2010 Jones EL, Sharp S, Aarsland D, Londos E, Ballard C. P1-066: A DYRK1A polymorphism and dementia Alzheimer's & Dementia. 6: S192-S193. DOI: 10.1016/J.Jalz.2010.05.614  0.351
2009 Sonnesyn H, Nilsen DW, Rongve A, Nore S, Ballard C, Tysnes OB, Aarsland D. High prevalence of orthostatic hypotension in mild dementia. Dementia and Geriatric Cognitive Disorders. 28: 307-13. PMID 19828952 DOI: 10.1159/000247586  0.34
2009 Sabbagh MN, Adler CH, Lahti TJ, Connor DJ, Vedders L, Peterson LK, Caviness JN, Shill HA, Sue LI, Ziabreva I, Perry E, Ballard CG, Aarsland D, Walker DG, Beach TG. Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Disease and Associated Disorders. 23: 295-7. PMID 19812474 DOI: 10.1097/Wad.0B013E31819C5Ef4  0.434
2009 Sharp SI, Francis PT, Elliott MS, Kalaria RN, Bajic N, Hortobagyi T, Ballard CG. Choline acetyltransferase activity in vascular dementia and stroke. Dementia and Geriatric Cognitive Disorders. 28: 233-8. PMID 19776575 DOI: 10.1159/000239235  0.418
2009 Ballard C, Margallo-Lana M, O'Brien JT, James I, Howard R, Fossey J. Top cited papers in International Psychogeriatrics: 6a. Quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills, and psychotropic drugs. International Psychogeriatrics / Ipa. 21: 1026-30. PMID 19772685 DOI: 10.1017/S1041610209990998  0.315
2009 Ballard C, Brown R, Fossey J, Douglas S, Bradley P, Hancock J, James IA, Juszczak E, Bentham P, Burns A, Lindesay J, Jacoby R, O'Brien J, Bullock R, Johnson T, et al. Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial). The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 17: 726-33. PMID 19700946 DOI: 10.1097/Jgp.0B013E3181B0F8C0  0.368
2009 Ballard C, Corbett A, Chitramohan R, Aarsland D. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions. Current Opinion in Psychiatry. 22: 532-540. PMID 19696673 DOI: 10.1097/Yco.0B013E32833111F9  0.427
2009 Jones R, Sheehan B, Phillips P, Juszczak E, Adams J, Baldwin A, Ballard C, Banerjee S, Barber B, Bentham P, Brown R, Burns A, Dening T, Findlay D, Gray R, et al. DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. Trials. 10: 57. PMID 19630974 DOI: 10.1186/1745-6215-10-57  0.442
2009 Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, Leroi I, Pozo-Rodriguez F, Minthon L, Londos E. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial Lancet Neurology. 8: 613-618. PMID 19520613 DOI: 10.1016/S1474-4422(09)70146-2  0.443
2009 Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, Lyketsos CG. Management of agitation and aggression associated with Alzheimer disease. Nature Reviews. Neurology. 5: 245-55. PMID 19488082 DOI: 10.1038/Nrneurol.2009.39  0.382
2009 Allan LM, Ballard CG, Rowan EN, Kenny RA. Incidence and prediction of falls in dementia: a prospective study in older people. Plos One. 4: e5521. PMID 19436724 DOI: 10.1371/Journal.Pone.0005521  0.36
2009 Elliott MS, Ballard CG, Kalaria RN, Perry R, Hortobágyi T, Francis PT. Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition. Brain : a Journal of Neurology. 132: 1858-65. PMID 19433439 DOI: 10.1093/Brain/Awp069  0.385
2009 Chalmers KA, Wilcock GK, Vinters HV, Perry EK, Perry R, Ballard CG, Love S. Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. Journal of Neurology. 256: 717-20. PMID 19240967 DOI: 10.1007/S00415-009-5000-2  0.375
2009 Aarsland D, Londos E, Ballard C. Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity. International Psychogeriatrics. 21: 216-219. PMID 19173762 DOI: 10.1017/S1041610208008612  0.449
2009 Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, Gill R, Juszczak E, Yu LM, Jacoby R. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. The Lancet. Neurology. 8: 151-7. PMID 19138567 DOI: 10.1016/S1474-4422(08)70295-3  0.346
2009 Jones EL, Hanney M, Francis PT, Ballard CG. Amyloid beta concentrations in older people with Down syndrome and dementia. Neuroscience Letters. 451: 162-4. PMID 19111900 DOI: 10.1016/J.Neulet.2008.12.030  0.388
2009 Lane R, He Y, Morris C, Leverenz JB, Emre M, Ballard C. BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 392-400. PMID 19006190 DOI: 10.1002/Mds.22357  0.419
2009 Ballard CG, Kossakowski K, MacInnes N, Aarsland D. Dementia with Lewy bodies and Parkinson disease dementia Hot Topics in Neurology and Psychiatry. DOI: 10.4147/Htn-090511  0.448
2008 Aarsland D, Rongve A, Nore SP, Skogseth R, Skulstad S, Ehrt U, Hoprekstad D, Ballard C. Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dementia and Geriatric Cognitive Disorders. 26: 445-452. PMID 18974647 DOI: 10.1159/000165917  0.417
2008 Ballard C, Day S, Sharp S, Wing G, Sorensen S. Neuropsychiatric symptoms in dementia: importance and treatment considerations. International Review of Psychiatry (Abingdon, England). 20: 396-404. PMID 18925489 DOI: 10.1080/09540260802099968  0.429
2008 Sharp SI, Ballard CG, Ziabreva I, Piggott MA, Perry RH, Perry EK, Aarsland D, Ehrt U, Larsen JP, Francis PT. Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia. Dementia and Geriatric Cognitive Disorders. 26: 330-8. PMID 18841018 DOI: 10.1159/000161058  0.314
2008 Jones EL, Margallo-Lana M, Prasher VP, Ballard CG. The extended tau haplotype and the age of onset of dementia in Down syndrome. Dementia and Geriatric Cognitive Disorders. 26: 199-202. PMID 18765933 DOI: 10.1159/000152044  0.408
2008 Ballard C, Sauter M, Scheltens P, He Y, Barkhof F, van Straaten EC, van der Flier WM, Hsu C, Wu S, Lane R. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Current Medical Research and Opinion. 24: 2561-74. PMID 18674411 DOI: 10.1185/03007990802328142  0.342
2008 Wood-Mitchell A, James IA, Waterworth A, Swann A, Ballard C. Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. Age and Ageing. 37: 547-52. PMID 18641003 DOI: 10.1093/Ageing/Afn135  0.348
2008 Skogseth R, Mulugeta E, Ballard C, Rongve A, Nore S, Alves G, Aarsland D. Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Dementia and Geriatric Cognitive Disorders. 25: 559-563. PMID 18536520 DOI: 10.1159/000137671  0.372
2008 Lowery DP, Wesnes K, Brewster N, Ballard C. Quantifying the association between computerised measures of attention and confusion assessment method defined delirium: a prospective study of older orthopaedic surgical patients, free of dementia. International Journal of Geriatric Psychiatry. 23: 1253-1260. PMID 18500690 DOI: 10.1002/Gps.2059  0.306
2008 MacInnes N, Iravani MM, Perry E, Piggott M, Perry R, Jenner P, Ballard C. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 869-78. PMID 18401540 DOI: 10.1007/S00702-008-0027-6  0.349
2008 Ballard C, Lana MM, Theodoulou M, Douglas S, McShane R, Jacoby R, Kossakowski K, Yu LM, Juszczak E. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). Plos Medicine. 5: e76. PMID 18384230 DOI: 10.1371/Journal.Pmed.0050076  0.429
2008 Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Pharmacogenetics and Genomics. 18: 289-98. PMID 18334913 DOI: 10.1097/Fpc.0B013E3282F63F29  0.382
2008 Mulugeta E, Molina-Holgado F, Elliott MS, Hortobagyi T, Perry R, Kalaria RN, Ballard CG, Francis PT. Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia. Dementia and Geriatric Cognitive Disorders. 25: 278-86. PMID 18303264 DOI: 10.1159/000118633  0.376
2008 Wilcock GK, Ballard CG, Cooper JA, Loft H. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. The Journal of Clinical Psychiatry. 69: 341-8. PMID 18294023 DOI: 10.4088/Jcp.V69N0302  0.428
2008 Aarsland D, Kurz M, Beyer M, Bronnick K, Nore SP, Ballard C. Early Discriminatory Diagnosis of Dementia with Lewy Bodies The Emerging Role of CSF and Imaging Biomarkers Dementia and Geriatric Cognitive Disorders. 25: 195-205. PMID 18204253 DOI: 10.1159/000113417  0.383
2008 Andersson M, Hansson O, Minthon L, Ballard CG, Londos E. The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies. International Journal of Geriatric Psychiatry. 23: 192-8. PMID 17621385 DOI: 10.1002/Gps.1861  0.415
2008 Korczyn AD, Aarsland D, Ballard CG, Kossakowski K, MacInnes N, Moretti R, Torre P. Parkinson/Dementia complex and Lewy body dementia: perspectives and treatments Hot Topics in Neurology and Psychiatry. DOI: 10.4147/Htn-090500  0.42
2008 Ballard C, Sorensen S, Aarsland D. Pharmacological Treatment of Alzheimer's Disease European Neurological Review. 3: 23. DOI: 10.17925/Enr.2008.03.01.23  0.362
2008 Ballard C. Antipsychotics: No quick fix for people with dementia British Journal of Neuroscience Nursing. 4: 261-262. DOI: 10.12968/Bjnn.2008.4.6.30009  0.397
2008 Skogseth R, Mulugeta E, Jones E, Ballard C, Rongve A, Nore S, Alves G, Aarsland D. Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer's Disease (vol 25, pg 559, 2008) Dementia and Geriatric Cognitive Disorders. 26: 290-290. DOI: 10.1159/000163581  0.342
2008 Clarke NA, Hartmann T, Tomic I, Jones EL, Ballard CG, Francis PT. P4-064: Neuroleptic medication is associated with selective alterations in VCSF Aβ40 and tau in patients with intractable unipolar depression Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2129  0.3
2008 Mulugeta E, Skogseth R, Alves G, Jones E, Rongve A, Nore E, Tysnes O, Ballard C, Larsen JP, Aarsland D. P3-087: Neuropsychiatric correlates of CSF Tau and P-Tau in dementia Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1651  0.344
2008 Warren FE, Sharp SI, Lakics V, Boess FG, Ballard CG, Ziabreva I, Perry EK, Aarsland D, Larsen J, Francis PT. P2-226: Association of proteasome subunit expression with reduced proteolytic activity in dementia with Lewy bodies and Parkinson's disease dementia Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1301  0.425
2008 Rongve A, Aarsland D, Nore SP, Skogseth R, Skulstad S, Ehrt U, Hoprekstad D, Ballard C. P2-225: The frequency of dementia with Lewy bodies in a community-based referral sample of mild dementia Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1300  0.378
2008 Andersson M, Hansson O, Minthon L, Ballard CG, Londos E. P2-214: Blood pressure reaction to orthostatic challenge is different in dementia with Lewy bodies Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1289  0.303
2007 Ballard C, Clack H, Green D. Postoperative cognitive decline, dementia and anaesthesia British Journal of Hospital Medicine. 68: 576-577. PMID 18087841 DOI: 10.12968/Hmed.2007.68.11.27676  0.358
2007 Ballard C. Agitation and Psychosis in Dementia American Journal of Geriatric Psychiatry. 15: 913-917. PMID 17974863 DOI: 10.1097/Jgp.0B013E3181584268  0.451
2007 Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, Burns AS, Holmes C, Jacoby R, Johnson T, Knapp M, Lindesay J, O'Brien JT, Wilcock G, Katona C, et al. Donepezil for the treatment of agitation in Alzheimer's disease. The New England Journal of Medicine. 357: 1382-92. PMID 17914039 DOI: 10.1056/Nejmoa066583  0.381
2007 Ballard C, Sorensen S, Sharp S. Pharmacological therapy for people with Alzheimer's disease: the balance of clinical effectiveness, ethical issues and social and healthcare costs. Journal of Alzheimer's Disease. 12: 53-59. PMID 17851194 DOI: 10.3233/Jad-2007-12106  0.374
2007 Piggott MA, Ballard CG, Rowan E, Holmes C, McKeith IG, Jaros E, Perry RH, Perry EK. Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Synapse (New York, N.Y.). 61: 903-11. PMID 17663455 DOI: 10.1002/Syn.20441  0.378
2007 Blesa R, Ballard C, Orgogozo J, Lane R, Thomas SK. Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease Neurology. 69. PMID 17646620 DOI: 10.1212/01.Wnl.0000281848.25142.11  0.4
2007 Ziabreva I, Ballard C, Johnson M, Larsen JP, McKeith I, Perry R, Aarsland D, Perry E. Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit. Neuropathology and Applied Neurobiology. 33: 586-590. PMID 17573814 DOI: 10.1111/J.1365-2990.2007.00848.X  0.378
2007 Ballard CG, Chalmers KA, Todd C, McKeith IG, O'Brien JT, Wilcock G, Love S, Perry EK. Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. Neurology. 68: 1726-9. PMID 17502555 DOI: 10.1212/01.Wnl.0000261920.03297.64  0.411
2007 Sharp SI, Ballard CG, Chen CP, Francis PT. Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 15: 435-7. PMID 17463193 DOI: 10.1097/01.Jgp.0000237065.78966.1B  0.331
2007 Ballard C, Sharp S, Fossey J. Time to discontinuation similar for atypical antipsychotic drugs and placebo in people with Alzheimer's disease. Evidence-Based Mental Health. 10: 58-58. PMID 17459989 DOI: 10.1136/Ebmh.10.2.58  0.355
2007 Lowery DP, Wesnes K, Ballard CG. Subtle attentional deficits in the absence of dementia are associated with an increased risk of post-operative delirium. Dementia and Geriatric Cognitive Disorders. 23: 390-4. PMID 17396030 DOI: 10.1159/000101453  0.308
2007 Ballard C, Fossey J, Sharp S. Antipsychotics in patients with Alzheimer's disease--what is their clinical value? Nature Reviews Neurology. 3: 248-249. PMID 17389878 DOI: 10.1038/Ncpneuro0472  0.368
2007 Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, McKeith IG, Kenny RA. Autonomic dysfunction in dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 671-7. PMID 17178816 DOI: 10.1136/Jnnp.2006.102343  0.453
2007 Robinson L, Hutchings D, Dickinson H, Corner L, Beyer F, Finch T, Hughes J, Vanoli A, Ballard C, Bond J. Effectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic review International Journal of Geriatric Psychiatry. 22: 9-22. PMID 17096455 DOI: 10.1002/Gps.1643  0.327
2007 Firbank MJ, Burton EJ, Barber R, Stephens S, Kenny RA, Ballard C, Kalaria RN, O'Brien JT. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiology of Aging. 28: 1664-9. PMID 16934370 DOI: 10.1016/J.Neurobiolaging.2006.07.009  0.36
2007 Piggott MA, Ballard CG, Dickinson HO, McKeith IG, Perry RH, Perry EK. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 231-44. PMID 16448581 DOI: 10.1017/S146114570600647X  0.355
2007 Ballard C, Clack H, Green D. Post-operative cognitive decline, dementia and anaesthesia British Journal of Neuroscience Nursing. 3: 302-303. DOI: 10.12968/Bjnn.2007.3.7.24270  0.427
2006 Ballard C, Ziabreva I, Perry R, Larsen JP, O'Brien J, McKeith I, Perry E, Aarsland D. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology. 67: 1931-1934. PMID 17159096 DOI: 10.1212/01.Wnl.0000249130.63615.Cc  0.457
2006 Ziabreva I, Perry E, Perry R, Minger SL, Ekonomou A, Przyborski S, Ballard C. Altered neurogenesis in Alzheimer's disease Journal of Psychosomatic Research. 61: 311-316. PMID 16938507 DOI: 10.1016/J.Jpsychores.2006.07.017  0.384
2006 Kurz MW, Schlitter AM, Larsen JP, Ballard C, Aarsland D. Familial occurrence of dementia and parkinsonism: a systematic review. Dementia and Geriatric Cognitive Disorders. 22: 288-295. PMID 16921239 DOI: 10.1159/000095159  0.398
2006 Allan L, McKeith I, Ballard C, Kenny RA. The prevalence of autonomic symptoms in dementia and their association with physical activity, activities of daily living and quality of life. Dementia and Geriatric Cognitive Disorders. 22: 230-237. PMID 16902277 DOI: 10.1159/000094971  0.347
2006 Ballard C, Fox C. Effectiveness of collaborative care for elderly adults with Alzheimer's disease in primary care. Lancet Neurology. 5: 644-645. PMID 16857569 DOI: 10.1016/S1474-4422(06)70507-5  0.319
2006 Robinson L, Hutchings D, Corner L, Beyer F, Dickinson H, Vanoli A, Finch T, Hughes J, Ballard C, May C, Bond J. A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. Health Technology Assessment. 10. PMID 16849002 DOI: 10.3310/Hta10260  0.359
2006 Ballard C, Lane R, Barone P, Ferrara R, Tekin S. Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias. International Journal of Clinical Practice. 60: 639-45. PMID 16805745 DOI: 10.1111/J.1368-5031.2006.00967.X  0.395
2006 Ballard C, Howard R. Neuroleptic drugs in dementia: benefits and harm. Nature Reviews Neuroscience. 7: 492-500. PMID 16715057 DOI: 10.1038/Nrn1926  0.4
2006 Sauer J, ffytche DH, Ballard C, Brown RG, Howard R. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity. Brain : a Journal of Neurology. 129: 1780-8. PMID 16670180 DOI: 10.1093/Brain/Awl102  0.39
2006 Lewis H, Beher D, Cookson N, Oakley A, Piggott M, Morris CM, Jaros E, Perry R, Ince P, Kenny RA, Ballard CG, Shearman MS, Kalaria RN. Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathology and Applied Neurobiology. 32: 103-18. PMID 16599940 DOI: 10.1111/J.1365-2990.2006.00696.X  0.325
2006 Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial Bmj. 332: 756-761. PMID 16543297 DOI: 10.1136/Bmj.38782.575868.7C  0.337
2006 Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease Cochrane Database of Systematic Reviews (Online). PMID 16437455 DOI: 10.1002/14651858.Cd003476.Pub2  0.403
2006 Pimlott SL, Piggott M, Ballard C, McKeith I, Perry R, Kometa S, Owens J, Wyper D, Perry E. Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiology of Disease. 21: 50-6. PMID 16023355 DOI: 10.1016/J.Nbd.2005.06.008  0.307
2006 Ziabreva I, Ballard CG, Aarsland D, Larsen JP, McKeith IG, Perry RH, Perry EK. Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiology of Aging. 27: 433-8. PMID 15913843 DOI: 10.1016/J.Neurobiolaging.2005.02.004  0.396
2006 Rongve A, Aarsland D, Ballard C. Current perspectives in dementia with Lewy bodies Aging Health. 2: 461-472. DOI: 10.2217/1745509X.2.3.461  0.42
2006 Ballard C. Dementia with Lewy Bodies and Parkinson's Disease Dementia Editors: JOHN O'BRIEN, IAN MCKEITH, DAVID AMES AND EDMOND CHIU, London, Taylor and Francis, 2005, £75.00 Hard cover, pp. 264 ISBN 1 8418 4491 8 International Psychogeriatrics. 18: 763-764. DOI: 10.1017/S1041610206244405  0.373
2006 Aman Y, Troakes C, Ballard C, Malcangio M. P2-010: INVOLVEMENT OF ELEVATED NEUROINFLAMMATION IN KEY REGIONS OF THE PAIN PATHWAY IN NOCICEPTIVE PROCESSING IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P668-P668. DOI: 10.1016/J.Jalz.2018.06.694  0.302
2006 Devanand DP, Cummings JL, Ballard C, Foff E, Youakim J, Owen R, Knowles M, Tariot PN, Stankovic S. F4-03-04: A SUMMARY OF THE RATIONALE AND DESIGN OF THE HARMONY STUDY: A PHASE 3 STUDY TO EVALUATE PIMAVANSERIN FOR THE TREATMENT OF HALLUCINATIONS AND DELUSIONS ASSOCIATED WITH DEMENTIA-RELATED PSYCHOSIS Alzheimer's & Dementia. 14: P1387-P1387. DOI: 10.1016/J.Jalz.2018.06.2875  0.308
2006 Aman Y, Pitcher T, Ballard C, Malcangio M. P4-018: IMPAIRED CHRONIC PAIN-LIKE BEHAVIOUR AND DISRUPTION OF OPIOIDERGIC SYSTEM IN TASTPM MODEL OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1439-P1440. DOI: 10.1016/J.Jalz.2018.06.2420  0.327
2006 Ballard C, Atri A, Boneva N, Cummings JL, Frölich L, Molinuevo JL, Raket LL, Tariot PN. P3-003: IDENTIFYING ENRICHMENT FACTORS THAT PREDICT ALZHEIMER'S DISEASE PROGRESSION: AN ANALYSIS OF THREE RANDOMIZED, CONTROLLED TRIALS Alzheimer's & Dementia. 14: P1062-P1063. DOI: 10.1016/J.Jalz.2018.06.1358  0.346
2005 Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M. The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. The American Journal of Psychiatry. 162: 2078-85. PMID 16263847 DOI: 10.1176/Appi.Ajp.162.11.2078  0.39
2005 Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Annals of Neurology. 58: 773-6. PMID 16240351 DOI: 10.1002/Ana.20635  0.432
2005 McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.Wnl.0000187889.17253.B1  0.413
2005 Allan LM, Ballard CG, Burn DJ, Kenny RA. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. Journal of the American Geriatrics Society. 53: 1681-7. PMID 16181166 DOI: 10.1111/J.1532-5415.2005.53552.X  0.448
2005 Aarsland D, Sharp S, Ballard C. Psychiatric and behavioral symptoms in Alzheimer's disease and other dementias: etiology and management. Current Neurology and Neuroscience Reports. 5: 345-54. PMID 16131417 DOI: 10.1007/S11910-005-0058-4  0.376
2005 Ballard CG, Perry RH, McKeith IG, Perry EK. Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies. International Journal of Geriatric Psychiatry. 20: 872-5. PMID 16116579 DOI: 10.1002/Gps.1378  0.487
2005 Rowan E, Morris CM, Stephens S, Ballard C, Dickinson H, Rao H, Saxby BK, McLaren AT, Kalaria RN, Kenny RA. Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects >75 years of age. Stroke; a Journal of Cerebral Circulation. 36: 1864-8. PMID 16051894 DOI: 10.1161/01.Str.0000177524.17424.2A  0.35
2005 Ballard CG, Greig NH, Guillozet-Bongaarts AL, Enz A, Darvesh S. Cholinesterases: roles in the brain during health and disease. Current Alzheimer Research. 2: 307-18. PMID 15974896 DOI: 10.2174/1567205054367838  0.389
2005 Ballard C, Cream J. Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh International Psychogeriatrics. 17: 4-12. PMID 15945588 DOI: 10.1017/S1041610205221026  0.345
2005 Tasker A, Perry EK, Ballard CG. Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment. Expert Review of Neurotherapeutics. 5: 101-6. PMID 15853480 DOI: 10.1586/14737175.5.1.101  0.461
2005 Holmes C, Ballard C, Lehmann D, David Smith A, Beaumont H, Day IN, Nadeem Khan M, Lovestone S, McCulley M, Morris CM, Munoz DG, O'Brien K, Russ C, Del Ser T, Warden D. Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 640-3. PMID 15834019 DOI: 10.1136/Jnnp.2004.039321  0.36
2005 Ballard C, Morris C, Kalaria R, McKeith I, Perry R, Perry E. The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients. Dementia and Geriatric Cognitive Disorders. 19: 357-60. PMID 15802910 DOI: 10.1159/000084705  0.406
2005 Ballard C, Margallo-Lana M, Juszczak E, Douglas S, Swann A, Thomas A, O'Brien J, Everratt A, Sadler S, Maddison C, Lee L, Bannister C, Elvish R, Jacoby R. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. Bmj (Clinical Research Ed.). 330: 874. PMID 15722369 DOI: 10.1136/Bmj.38369.459988.8F  0.429
2005 Stephens S, Kenny RA, Rowan E, Kalaria RN, Bradbury M, Pearce R, Wesnes K, Ballard CG. Association between mild vascular cognitive impairment and impaired activities of daily living in older stroke survivors without dementia. Journal of the American Geriatrics Society. 53: 103-7. PMID 15667385 DOI: 10.1111/J.1532-5415.2005.53019.X  0.392
2005 Tildesley NT, Kennedy DO, Perry EK, Ballard CG, Wesnes KA, Scholey AB. Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiology & Behavior. 83: 699-709. PMID 15639154 DOI: 10.1016/J.Physbeh.2004.09.010  0.335
2005 Allan LM, Kerr SR, Ballard CG, Allen J, Murray A, McLaren AT, Kenny RA. Autonomic function assessed by heart rate variability is normal in Alzheimer's disease and vascular dementia. Dementia and Geriatric Cognitive Disorders. 19: 140-4. PMID 15627761 DOI: 10.1159/000082885  0.397
2005 Thomas A, Ballard C, Kenny RA, O'Brien J, Oakley A, Kalaria R. Correlation of entorhinal amyloid with memory in Alzheimer's and vascular but not Lewy body dementia. Dementia and Geriatric Cognitive Disorders. 19: 57-60. PMID 15572872 DOI: 10.1159/000082349  0.426
2005 Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. The Journal of Clinical Psychiatry. 66: 633-637. DOI: 10.4088/Jcp.V66N0514  0.41
2005 Robinson L, Hughes J, Daley S, Keady J, Ballard C, Volicer L. End-of-life care and dementia Reviews in Clinical Gerontology. 15: 135-148. DOI: 10.1017/S0959259806001833  0.373
2005 Sharp SI, Francis PT, Ballard CG. Neurochemistry of severe dementia Reviews in Clinical Gerontology. 15: 105-123. DOI: 10.1017/S0959259805001681  0.435
2005 Kenny RA, Pearce R, Ballard C, Hampton J, Kerr S, Widdrington M. Prevalence and profile of cognitive impairment and dementia in patients with carotid sinus syndrome (CSS) and carotid sinus hypersensitivity (CSH) Europace. 7. DOI: 10.1016/J.Eupc.2005.08.013  0.383
2004 Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T. Towards defining the neuropathological substrates of vascular dementia. Journal of the Neurological Sciences. 226: 75-80. PMID 15537525 DOI: 10.1016/J.Jns.2004.09.019  0.437
2004 Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment. Neurology. 63: 1399-402. PMID 15505155 DOI: 10.1212/01.Wnl.0000141851.93193.17  0.383
2004 Stephens S, Kenny RA, Rowan E, Allan L, Kalaria RN, Bradbury M, Ballard CG. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke. International Journal of Geriatric Psychiatry. 19: 1053-7. PMID 15481073 DOI: 10.1002/Gps.1209  0.358
2004 Ballard CG, Burton EJ, Barber R, Stephens S, Kenny RA, Kalaria RN, O'Brien JT. NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology. 63: 983-8. PMID 15452287 DOI: 10.1212/01.Wnl.0000138435.19761.93  0.408
2004 Aarsland D, Ballard CG, Halliday G. Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity? Journal of Geriatric Psychiatry and Neurology. 17: 137-45. PMID 15312277 DOI: 10.1177/0891988704267470  0.462
2004 Cormack F, Gray A, Ballard C, Tovée MJ. A failure of 'pop-out' in visual search tasks in dementia with Lewy Bodies as compared to Alzheimer's and Parkinson's disease. International Journal of Geriatric Psychiatry. 19: 763-772. PMID 15290700 DOI: 10.1002/Gps.1159  0.385
2004 Kenny RA, Shaw FE, O'Brien JT, Scheltens PH, Kalaria R, Ballard C. Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 966-71. PMID 15201351 DOI: 10.1136/Jnnp.2003.023812  0.409
2004 Margallo-Lana M, Morris CM, Gibson AM, Tan AL, Kay DW, Tyrer SP, Moore BP, Ballard CG. Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology. 62: 1996-8. PMID 15184603 DOI: 10.1212/01.Wnl.0000129275.13169.Be  0.387
2004 Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, Nagy Z, Perry EK, Joachim C, Jaros E, O'Brien JT, Perry RH, McKeith IG. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. The American Journal of Psychiatry. 161: 843-9. PMID 15121649 DOI: 10.1176/Appi.Ajp.161.5.843  0.456
2004 Burton EJ, Kenny RA, O'Brien J, Stephens S, Bradbury M, Rowan E, Kalaria R, Firbank M, Wesnes K, Ballard C. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke; a Journal of Cerebral Circulation. 35: 1270-5. PMID 15118186 DOI: 10.1161/01.Str.0000126041.99024.86  0.312
2004 Cormack F, Aarsland D, Ballard C, Tovée MJ. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia International Journal of Geriatric Psychiatry. 19: 371-377. PMID 15065231 DOI: 10.1002/Gps.1094  0.467
2004 Ballard CG, Thomas A, Fossey J, Lee L, Jacoby R, Lana MM, Bannister C, McShane R, Swann A, Juszczak E, O'Brien JT. A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. The Journal of Clinical Psychiatry. 65: 114-9. PMID 14744180 DOI: 10.4088/Jcp.V65N0120  0.417
2004 Ballard CG. Definition and diagnosis of dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders. 17: 15-24. PMID 14676465 DOI: 10.1159/000074678  0.416
2004 Ballard C, Hulford L. Drugs used to relieve behavioural symptoms of dementia Nursing and Residential Care. 6: 342-346. DOI: 10.12968/Nrec.2004.6.7.13246  0.319
2004 James I, Douglas S, Ballard C. Different forms of psychological interventions in dementia Nursing and Residential Care. 6: 288-291. DOI: 10.12968/Nrec.2004.6.6.12999  0.375
2004 Holmes C, Ballard C. Aromatherapy in dementia Advances in Psychiatric Treatment. 10: 296-300. DOI: 10.1192/Apt.10.4.296  0.374
2004 Douglas S, James I, Ballard C. Non-pharmacological interventions in dementia Advances in Psychiatric Treatment. 10: 171-177. DOI: 10.1192/Apt.10.3.171  0.333
2004 Ballard C. S3-04-04 Dementia with Lewy bodies: update definition and clinical studies Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80172-6  0.396
2004 Ballard C, Perry E, Lehmann D, Wesnes K, Holmes C. Butyrylcholinesterase: Impact on symptoms and progression of cognitive impairment in dementia Neurobiology of Aging. 25. DOI: 10.1016/J.Neurobiolaging.2003.12.002  0.404
2004 Ballard C, Fossey J. Clinical management of dementia Psychiatry Mmc. 7: 88-93. DOI: 10.1016/J.Mppsy.2007.12.007  0.398
2004 Aarsland D, Ballard C. Psychiatric issues in non-Alzheimer dementias Clinical Neuroscience Research. 3: 397-412. DOI: 10.1016/J.Cnr.2004.04.006  0.464
2003 Ballard C, Stephens S, McLaren A, Wesnes K, Kenny R. Mild cognitive impairment and vascular cognitive impairment in stroke patients. International Psychogeriatrics / Ipa. 15: 123-6. PMID 16191228 DOI: 10.1017/S1041610203009074  0.397
2003 Potkins D, Myint P, Bannister C, Tadros G, Chithramohan R, Swann A, O'Brien J, Fossey J, George E, Ballard C, Margallo-Lana M. Language impairment in dementia: impact on symptoms and care needs in residential homes. International Journal of Geriatric Psychiatry. 18: 1002-6. PMID 14618551 DOI: 10.1002/Gps.1002  0.317
2003 Ballard C, Rowan E, Stephens S, Kalaria R, Kenny RA. Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors >75 years of age. Stroke; a Journal of Cerebral Circulation. 34: 2440-4. PMID 14512580 DOI: 10.1161/01.Str.0000089923.29724.Ce  0.401
2003 Perry NS, Bollen C, Perry EK, Ballard C. Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacology, Biochemistry, and Behavior. 75: 651-9. PMID 12895683 DOI: 10.1016/S0091-3057(03)00108-4  0.357
2003 O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST. Vascular cognitive impairment. The Lancet. Neurology. 2: 89-98. PMID 12849265 DOI: 10.1016/S1474-4422(03)00305-3  0.333
2003 Perry E, McKeith I, Ballard C. Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies. Neurology. 60: 1852-1853. PMID 12796550 DOI: 10.1212/01.Wnl.0000068336.84399.9E  0.442
2003 Burton E, Ballard C, Stephens S, Kenny RA, Kalaria R, Barber R, O'Brien J. Hyperintensities and fronto-subcortical atrophy on MRI are substrates of mild cognitive deficits after stroke. Dementia and Geriatric Cognitive Disorders. 16: 113-8. PMID 12784036 DOI: 10.1159/000070684  0.325
2003 Margallo-Lana ML, Ballard C, Morris C, Kay D, Tyrer S, Moore B. Cholinesterase Inhibitors In The Treatment Of Dementia International Journal of Geriatric Psychiatry. 18: 458-459. PMID 12766925 DOI: 10.1002/Gps.809  0.362
2003 Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O'Brien JT, Scheltens Ph, McKeith IG, Williams D, Ballard C, Barkhof F. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage. 18: 895-907. PMID 12725765 DOI: 10.1016/S1053-8119(03)00041-7  0.341
2003 Ballard C, Stephens S, Kenny R, Kalaria R, Tovee M, O’Brien J. Profile of Neuropsychological Deficits in Older Stroke Survivors without Dementia Dementia and Geriatric Cognitive Disorders. 16: 52-56. PMID 12714801 DOI: 10.1159/000069994  0.367
2003 O'Brien KK, Saxby BK, Ballard CG, Grace J, Harrington F, Ford GA, O'Brien JT, Swan AG, Fairbairn AF, Wesnes K, del Ser T, Edwardson JA, Morris CM, McKeith IG. Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics. 13: 231-9. PMID 12668920 DOI: 10.1097/00008571-200304000-00008  0.405
2003 McLaren AT, Allen J, Murray A, Ballard CG, Kenny RA. Cardiovascular effects of donepezil in patients with dementia. Dementia and Geriatric Cognitive Disorders. 15: 183-8. PMID 12626850 DOI: 10.1159/000068781  0.312
2003 McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O'Brien JT. Dementia with Lewy bodies. Seminars in Clinical Neuropsychiatry. 8: 46-57. PMID 12567332 DOI: 10.1053/Scnp.2003.50006  0.372
2003 Kalaria RN, Thomas A, Oakley A, Ince P, Tamaoka A, Mori H, Kenny RA, Ballard C. Cerebrovascular Amyloidosis and Dementia Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents. 3: 317-327. DOI: 10.2174/1568013033483267  0.388
2003 Lee L, Reichelt K, Ballard C, Perry E. Melissa aromatherapy as safe and effective treatment Nursing and Residential Care. 5: 80-82. DOI: 10.12968/Nrec.2003.5.2.11037  0.339
2003 Ballard C. Dementia: Management of behavioural and psychological symptoms Nordic Journal of Psychiatry. 57: 159-160. DOI: 10.1080/08039480310001571  0.391
2003 Ballard C, Kalaria R, Kenny R, Thomas A. Alzheimer's disease – a vascular dementia? Reviews in Clinical Gerontology. 13: 67-74. DOI: 10.1017/S0959259803013169  0.429
2003 Ballard CG, Perry EK. Butyrylcholinesterase: Potential importance for the symptoms and progression of cognitive decline in people with dementia Acta Neurologica Taiwanica. 12: 109-113.  0.307
2002 Kenny RAM, Kalaria R, Ballard C. Neurocardiovascular instability in cognitive impairment and dementia. Annals of the New York Academy of Sciences. 977: 183-195. PMID 12480751 DOI: 10.1111/J.1749-6632.2002.Tb04816.X  0.445
2002 Ballard C, Stephens S, McLaren A, Wesnes K, Kenny RA, Burton E, O'Brien J, Kalaria R. Neuropsychological deficits in older stroke patients. Annals of the New York Academy of Sciences. 977: 179-82. PMID 12480750 DOI: 10.1111/J.1749-6632.2002.Tb04815.X  0.345
2002 Ballard CG, Aarsland D, McKeith I, O'Brien J, Gray A, Cormack F, Burn D, Cassidy T, Starfeldt R, Larsen JP, Brown R, Tovee M. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology. 59: 1714-20. PMID 12473758 DOI: 10.1212/01.Wnl.0000036908.39696.Fd  0.341
2002 Burns A, Byrne JM, Ballard C, Holmes C. Sensory stimulation in dementia. Bmj. 325: 1312-1313. PMID 12468458 DOI: 10.1136/Bmj.325.7376.1312  0.382
2002 Lowery K, Ballard C, Rodgers H, McLaren A, O'Brien J, Rowan E, Stephens S. Cognitive decline in a prospectively studied group of stroke survivors, with a particular emphasis on the >75's. Age and Ageing. 31: 24-7. PMID 12450925 DOI: 10.1093/Ageing/31.Suppl_3.24  0.357
2002 Singleton AB, Wharton A, O'Brien KK, Walker MP, McKeith IG, Ballard CG, O'Brien J, Perry RH, Ince PG, Edwardson JA, Morris CM. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders. 14: 167-75. PMID 12411758 DOI: 10.1159/000066022  0.407
2002 Fossey J, Lee L, Ballard C. Dementia Care Mapping as a research tool for measuring quality of life in care settings: psychometric properties. International Journal of Geriatric Psychiatry. 17: 1064-70. PMID 12404656 DOI: 10.1002/Gps.708  0.307
2002 Ballard CG, O'Brien JT, Reichelt K, Perry EK. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. The Journal of Clinical Psychiatry. 63: 553-8. PMID 12143909 DOI: 10.4088/Jcp.V63N0703  0.353
2002 Ballard C, Johnson M, Piggott M, Perry R, O'Brien J, Rowan E, Perry E, Lantos P, Cairns N, Holmes C. A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies. Journal of Affective Disorders. 69: 219-23. PMID 12103469 DOI: 10.1016/S0165-0327(00)00375-X  0.323
2002 Colloby SJ, Fenwick JD, Williams ED, Paling SM, Lobotesis K, Ballard C, McKeith I, O'Brien JT. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. European Journal of Nuclear Medicine and Molecular Imaging. 29: 615-22. PMID 11976799 DOI: 10.1007/S00259-002-0778-5  0.406
2002 Barber R, McKeith I, Ballard C, O'Brien J. Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia Journal of Neurology, Neurosurgery, and Psychiatry. 72: 406-407. PMID 11861709 DOI: 10.1136/Jnnp.72.3.406  0.415
2002 Ballard C, Powell I, James I, Reichelt K, Myint P, Potkins D, Bannister C, Lana M, Howard R, O'Brien J, Swann A, Robinson D, Shrimanker J, Barber R. Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities. International Journal of Geriatric Psychiatry. 17: 140-145. PMID 11813276 DOI: 10.1002/Gps.543  0.304
2002 Ballard CG. Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition. European Neurology. 47: 64-70. PMID 11803198 DOI: 10.1159/000047952  0.37
2002 Hussain RI, Ballard CG, Edwardson JA, Morris CM. Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans. Neuroscience Letters. 317: 13-6. PMID 11750985 DOI: 10.1016/S0304-3940(01)02403-X  0.35
2002 Teahan O, Slade JY, Perry RH, Ballard CG, Kalaria RN. White matter pathology in Alzheimer's disease and vascular dementia: quantification by amyloid-beta precursor protein immunocytochemistry Neuropathology and Applied Neurobiology. 28: 168-168. DOI: 10.1046/J.1365-2990.2002.39286_52.X  0.4
2002 Burton E, Karas G, Paling S, Barber R, Williams E, Ballard C, McKeith I, Scheltens P, Barkhof F, O'Brien J. Patterns of Cerebral Atrophy in Dementia with Lewy Bodies Using Voxel-Based Morphometry Neuroimage. 17: 618-630. DOI: 10.1006/Nimg.2002.1197  0.399
2001 Court JA, Ballard CG, Piggott MA, Johnson M, O'Brien JT, Holmes C, Cairns N, Lantos P, Perry RH, Jaros E, Perry EK. Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies. Pharmacology, Biochemistry, and Behavior. 70: 571-9. PMID 11796155 DOI: 10.1016/S0091-3057(01)00644-X  0.318
2001 Middelkoop HA, van der Flier WM, Burton EJ, Lloyd AJ, Paling S, Barber R, Ballard C, McKeith IG, O'Brien JT. Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology. 57: 2117-20. PMID 11739838 DOI: 10.1212/Wnl.57.11.2117  0.389
2001 Ballard CG, Margallo-Lana M, Fossey J, Reichelt K, Myint P, Potkins D, O'Brien J. A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments. The Journal of Clinical Psychiatry. 62: 631-6. PMID 11561936 DOI: 10.4088/Jcp.V62N0810  0.399
2001 Ballard C, Fossey J, Chithramohan R, Howard R, Burns A, Thompson P, Tadros G, Fairbairn A. Quality of care in private sector and NHS facilities for people with dementia: cross sectional survey Bmj. 323: 426-427. PMID 11520838 DOI: 10.1136/Bmj.323.7310.426  0.336
2001 Aarsland D, Ballard C, McKeith I, Perry RH, Larsen JP. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 13: 374-9. PMID 11514644 DOI: 10.1176/Appi.Neuropsych.13.3.374  0.393
2001 Howard R, Ballard C, O'Brien J, Burns A. Guidelines for the management of agitation in dementia International Journal of Geriatric Psychiatry. 16: 714-717. PMID 11466751 DOI: 10.1002/Gps.418  0.338
2001 O'Brien JT, Ballard CG. Drugs for Alzheimer's disease. Bmj (Clinical Research Ed.). 323: 123-4. PMID 11463665 DOI: 10.1136/Bmj.323.7305.123  0.432
2001 Campbell S, Stephens S, Ballard C. Dementia with Lewy bodies: clinical features and treatment. Drugs & Aging. 18: 397-407. PMID 11419914 DOI: 10.2165/00002512-200118060-00002  0.423
2001 Ballard C, O'Brien J, Gray A, Cormack F, Ayre G, Rowan E, Thompson P, Bucks R, McKeith I, Walker M, Tovee M. Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Archives of Neurology. 58: 977-82. PMID 11405813 DOI: 10.1001/Archneur.58.6.977  0.424
2001 Kalaria RN, Ballard C. Stroke and cognition. Current Atherosclerosis Reports. 3: 334-9. PMID 11389800 DOI: 10.1007/S11883-001-0028-5  0.356
2001 Aarsland D, Ballard C, Larsen JP, McKeith I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. International Journal of Geriatric Psychiatry. 16: 528-536. PMID 11376470 DOI: 10.1002/Gps.389  0.424
2001 Ballard C, O'Brien J, Morris C, Barber R, Swann A, Neill D, McKeith I. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease International Journal of Geriatric Psychiatry. 16: 499-503. PMID 11376466 DOI: 10.1002/Gps.381  0.473
2001 Ballard C, Walker M, O'Brien J, Rowan E, McKeith I. The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry. 16: 494-8. PMID 11376465 DOI: 10.1002/Gps.368  0.462
2001 O'Brien JT, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, Gholkar A, Crum WR, Rossor MN, Fox NC. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology. 56: 1386-8. PMID 11376193 DOI: 10.1212/Wnl.56.10.1386  0.364
2001 Ballard C, O'Brien J, James I, Mynt P, Lana M, Potkins D, Reichelt K, Lee L, Swann A, Fossey J. Quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills, and psychotropic drugs. International Psychogeriatrics / Ipa. 13: 93-106. PMID 11352339 DOI: 10.1017/S1041610201007499  0.344
2001 Jackson EJ, Rajah S, Morris C, Ballard C, Thomas AJ, O'Brien JT. Is apolipoprotein e4 associated with cognitive decline in depression? International Journal of Geriatric Psychiatry. 16: 436-7. PMID 11333434 DOI: 10.1002/Gps.347  0.305
2001 Singleton AB, Gibson AM, McKeith IG, Ballard CG, Edwardson JA, Morris CM. Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neuroscience Letters. 303: 33-6. PMID 11297817 DOI: 10.1016/S0304-3940(01)01694-9  0.401
2001 Margallo-Lana M, Reichelt K, Hayes P, Lee L, Fossey J, O'Brien J, Ballard C. Longitudinal comparison of depression, coping, and turnover among NHS and private sector staff caring for people with dementia. Bmj (Clinical Research Ed.). 322: 769-70. PMID 11282862 DOI: 10.1136/Bmj.322.7289.769  0.333
2001 Kalaria RN, Ballard CG, Ince PG, Kenny RA, McKeith IG, Morris CM, O'Brien JT, Perry EK, Perry RH, Edwardson JA. Multiple substrates of late-onset dementia: implications for brain protection. Novartis Foundation Symposium. 235: 49-60; discussion 60. PMID 11280033  0.352
2001 Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O'Brien JT. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology. 56: 643-9. PMID 11245717 DOI: 10.1212/Wnl.56.5.643  0.393
2001 Barber R, McKeith IG, Ballard C, Gholkar A, O'Brien JT. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Dementia and Geriatric Cognitive Disorders. 12: 198-205. PMID 11244213 DOI: 10.1159/000051258  0.366
2001 Ballard CG, O'Brien JT, Swann AG, Thompson P, Neill D, McKeith IG. The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. The Journal of Clinical Psychiatry. 62: 46-9. PMID 11235928 DOI: 10.4088/Jcp.V62N0110  0.469
2001 Margallo-Lana M, Swann A, O'Brien J, Fairbairn A, Reichelt K, Potkins D, Mynt P, Ballard C. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments International Journal of Geriatric Psychiatry. 16: 39-44. PMID 11180484 DOI: 10.1002/1099-1166(200101)16:1<39::Aid-Gps269>3.0.Co;2-F  0.382
2001 O'Brien J, Thomas A, Ballard C, Brown A, Ferrier N, Jaros E, Perry R. Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology. Biological Psychiatry. 49: 130-6. PMID 11164759 DOI: 10.1016/S0006-3223(00)00944-6  0.383
2000 Martin-Ruiz C, Court J, Lee M, Piggott M, Johnson M, Ballard C, Kalaria R, Perry R, Perry E. Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types. Acta Neurologica Scandinavica. Supplementum. 176: 34-41. PMID 11261803 DOI: 10.1034/J.1600-0404.2000.00305.X  0.414
2000 Potkins D, Bradley S, Shrimanker J, O'Brien J, Swann A, Ballard C. End of life treatment decisions in people with dementia: carers' views and the factors which influence them International Journal of Geriatric Psychiatry. 15: 1005-1008. PMID 11113979 DOI: 10.1002/1099-1166(200011)15:11<1005::Aid-Gps223>3.0.Co;2-0  0.364
2000 Singleton AB, Hall R, Ballard CG, Perry RH, Xuereb JH, Rubinsztein DC, Tysoe C, Matthews P, Cordell B, Kumar-Singh S, De Jonghe C, Cruts M, van Broeckhoven C, Morris CM. Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. Brain : a Journal of Neurology. 123: 2467-74. PMID 11099448 DOI: 10.1093/Brain/123.12.2467  0.347
2000 Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. International Journal of Geriatric Psychiatry. 15: 911-6. PMID 11044873 DOI: 10.1002/1099-1166(200010)15:10<911::Aid-Gps217>3.0.Co;2-T  0.362
2000 Lowery K, Buri H, Ballard C. What is the prevalence of environmental hazards in the homes of dementia sufferers and are they associated with falls. International Journal of Geriatric Psychiatry. 15: 883-6. PMID 11044868 DOI: 10.1002/1099-1166(200010)15:10<883::Aid-Gps981>3.0.Co;2-9  0.374
2000 Walker MP, Ayre GA, Perry EK, Wesnes K, McKeith IG, Tovee M, Edwardson JA, Ballard CG. Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 11: 327-35. PMID 11044778 DOI: 10.1159/000017262  0.455
Show low-probability matches.